WO2017142158A1 - Composition for skin anti-aging and wrinkle reduction, containing medicinal herb mixture extract as active ingredient - Google Patents

Composition for skin anti-aging and wrinkle reduction, containing medicinal herb mixture extract as active ingredient Download PDF

Info

Publication number
WO2017142158A1
WO2017142158A1 PCT/KR2016/010842 KR2016010842W WO2017142158A1 WO 2017142158 A1 WO2017142158 A1 WO 2017142158A1 KR 2016010842 W KR2016010842 W KR 2016010842W WO 2017142158 A1 WO2017142158 A1 WO 2017142158A1
Authority
WO
WIPO (PCT)
Prior art keywords
skin
ginger
extract
turmeric
aging
Prior art date
Application number
PCT/KR2016/010842
Other languages
French (fr)
Korean (ko)
Inventor
김종열
차성원
남지호
채성욱
임아랑
최송이
김영화
Original Assignee
한국 한의학 연구원
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국 한의학 연구원 filed Critical 한국 한의학 연구원
Publication of WO2017142158A1 publication Critical patent/WO2017142158A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A61K36/284Atractylodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9066Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Definitions

  • the present invention relates to a composition for improving skin aging and wrinkles, which contains a herb extract as an active ingredient, and specifically, a ginger mixed with a weight ratio of 1: 3 to 6: 6 to 3: 1, creation, turmeric and broiler mixture. It relates to a skin aging and wrinkle improvement composition containing the extract as an active ingredient.
  • the skin protects the organs of the body from stimulation of the external environment and plays an important role in maintaining homeostasis such as temperature control.
  • the skin is aged by various internal and external factors, and is classified into endogenous aging due to genetic causes and exogenous aging due to environmental causes.
  • photoaging means aging by ultraviolet (UV).
  • UV ultraviolet
  • ozone layer destruction due to environmental pollution has increased the amount of ultraviolet rays, and thus, research on photoaging has been focused (Wang SQ et al., 2010, Dermatol. Ther. 23 (1): 31-47).
  • cosmetic features such as roughness, loss of elasticity, wrinkles and irregular pigmentation are observed.
  • the main research field of photo-aging is about the change of skin wrinkles.
  • ginger Zingiber officinale
  • the raw materials of Chinese herbal medicines are used in various ways.
  • the harvested rhizome is called ginger, and the steamed or boiled ginger dried is called health ( ⁇ ), and the roasted and dried is called black river.
  • Ginger secretes digestive juices to promote appetite, promote gastrointestinal motility, aid in digestion and absorption, and is also used for asthma at the same time as it eliminates phlegm, lowers energy, stops vomiting, removes cold and boils (Clinical Traditional) Herbalogy, Younglimsa, 1997, 293-296; and above, Herbal Science, 1981, 203-204). It is also used for antipyretic drugs, blood circulation disorders, cold and cold. Aromatherapy ingredients increase blood circulation and body temperature, and take honey mixed with ginger juice to treat colds and coughs. On the other hand, health is used when metabolic function is lowered and is used as a treatment for cough, dizziness, cold hands and feet, low back pain, diarrhea and vomiting. It is also used for planting, boosting sheep and removing cold of five viscera.
  • Atractylodes lancea is a root stem in the genus (Compositae) and plant, which is distributed in North China, Shanxi, etc., and is irregularly bent cylindrical shape of 3 ⁇ 10cm long and 10 ⁇ 25mm in diameter, and the outer surface is made by dark ash.
  • pharmacological action is known to have a healthy, diuretic, sweating, sedative, hypoglycemic, tonic action. Creation is a perennial herb, which grows in mountains all over the country. In the fall, it is cut and washed in water to trim fine roots and to dry in the sun.
  • Curcuma longa also known as horseshoe turmeric, is cultivated in the sub-central part of Korea, and the roots are washed in water in autumn and boiled or steamed to dry.
  • the taste is spicy, bitter and very warm. Promotes circulation and blood circulation, eliminates blood, eases pain and smoothes menstruation.
  • biliary tract function liver detoxification function, analgesic action, uterine contraction action antibacterial action. It is used for amenorrhea, bleeding, and chest and stomach aches, swelling of arms, hepatitis, cholelithiasis, and bruising carbuncles.
  • broilers Cinnamomum cassia
  • product specifications also include relatively many types such as variometers, relations, plates, chains, and chains. It is tubular or rolled into stem shell, 5 ⁇ 50cm long, 1.5 ⁇ 5cm in diameter, and 0.1 ⁇ 0.5cm thick. The outer side is dark reddish brown and the inner side is reddish brown and smooth. It is easy to bend and its face is reddish brown with a thin layer of light brown color and slightly fibrous. It has a peculiar smell, tastes slightly sweet and very, later slightly mucus and astringent.
  • the noise person is weak in spleen and stomach, and the kidney is faithful, so the shape of the body is well-balanced up and down.
  • the woman is well-framed, dense, cute and appealing. Forehead comes out a little, eyes, nose, mouth is not big, and the eyes are young and regular ( ⁇ ⁇ ) can be called.
  • the skin is so soft and dense that there is little sweat, and a woman does not lose her hands even when working in winter.
  • Examples of known ginger, creation, turmeric and broiler mixed extract and skin wrinkle improvement or skin aging related technology cosmetic composition comprising a product dermis and ginger mixed extract having antioxidant and anti-aging effects in Korean Patent No. 1118765 And a method of manufacturing the same, a cosmetic composition for improving wrinkles is known from Korean Patent Publication No. 2008-0094457, and a cosmetic composition containing broiler extract is disclosed in Korean Patent Publication No. 2001-0055960. 0891986 discloses a herbal cosmetic composition containing a herbal extract and a herbal powder, but it is mentioned with respect to the cosmetic composition for skin wrinkle improvement and anti-aging containing the ginger, creation, turmeric and broiler mixed extract of the present invention as an active ingredient No bar
  • the present invention is derived from the above demands, ginger ( Zingiber officinale), Creation ( Atractylodes) lancea ), Curcuma Longa ) and Cinnamomum cassia ( Cinnamomum cassia ) relates to a composition for improving skin wrinkles and anti-aging containing the extract as an active ingredient, in particular ginger, creation, turmeric and broiler extract 1: 2.5 ⁇ 6.5: 2.5 ⁇ 6.5: 1
  • the mixed extract mixed in a weight ratio suppresses cellular damage by ultraviolet irradiation, significantly suppresses the expression of MMP-1, and in particular, confirms that there is an antiwrinkle effect on the noise person, thereby completing the present invention.
  • the present invention provides a cosmetic composition for skin wrinkle improvement and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
  • the present invention also provides a functional food composition for improving skin wrinkles and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
  • the present invention provides a pharmaceutical composition for preventing and treating skin wrinkles containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
  • the present invention relates to a composition for improving skin wrinkles and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient, in detail, the ginger, creation, turmeric and broiler extract 1: 2.5 ⁇ 6.5: 2.5 ⁇ 6.5 Mixed extracts mixed at a weight ratio of 1 to 1 inhibit cellular damage by UV irradiation and significantly inhibit the expression of MMP-1.
  • the blending ratio of ginger, crude, turmeric and broiler extracts is 1: 2.5 to 6.5: 2.5 to 6.5: 1 by weight, it is more effective to irradiate with ultraviolet rays than to mix with other blending ratios or to use ginger, crude, turmeric or broiler extracts alone. It suppresses cellular damage by and significantly suppresses the expression of MMP-1.
  • the active ingredient of the present invention is effective to improve the skin wrinkles to the noise person in the Sasang constitution classified in the oriental medicine can be usefully used as a cosmetic composition, health functional food composition and pharmaceutical composition of the noise person.
  • HaCaT cells human keratinocytes
  • mixing ratio mixing according to the weight ratio
  • of ginger, creation, turmeric and broiler mixed extract of the present invention 50 ⁇ g / ml and 100 ⁇ g / ml
  • UV Crosslinker, UltR5 Lum ultraviolet
  • Figure 2 is a result confirming the expression amount of MMP-1 by the mixing ratio (mixing according to the weight ratio) of the ginger, creation, turmeric and broiler mixed extract of the present invention.
  • 3 is a definition and diagram of the wrinkle parameters used in replica analysis.
  • Figure 4 is a result of the analysis of the R1 parameter of the replica wrinkle effect between the test group and the control group using a product containing ginger, the production, turmeric and broiler mixed extract in a weight ratio of 1: 6: 3: 1 .
  • (A) shows R1 values measured before use (0W), after 4 weeks of use (4W), after 8 weeks of use (8W) and after 12 weeks of use (12W). The change rate of R1 is shown based on the previous (0W).
  • * Means that there is a statistically significant difference compared to before using the product according to the present invention (week 0), ⁇ means that there is a statistically significant difference between the test group and the control group, * And ⁇ indicate that the p value is less than 0.05.
  • Figure 5 is a result of the analysis of the R4 parameter of the replica wrinkle effect between the test group and the control group using a product containing ginger, the production, turmeric and broiler mixed extract in a weight ratio of 1: 6: 3: 1 .
  • (A) shows R4 values measured before use (0W), after 4 weeks of use (4W), after 8 weeks of use (8W) and after 12 weeks of use (12W). The change rate of R4 is shown based on the previous (0W).
  • the present invention relates to a cosmetic composition for improving skin wrinkles and anti-aging containing ginger, extract, turmeric and broiler mixed extract as an active ingredient.
  • the ginger, creation, turmeric and broiler extract is preferably extracted using at least one solvent selected from water, C 1 ⁇ C 4 lower alcohol, propylene glycol, ethyl acetate, butylene glycol, glycerin, ether and chloroform, more Preferably hot water extraction is not limited to this.
  • the mixing ratio of the ginger, creation, turmeric and broiler extract is preferably 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, more preferably 1: 2.5 to 3.5: 5.5 to 6.5: 1 or 1: 5.5 to 6.5 : 2.5 to 3.5: 1 by weight, most preferably 1: 5.5 to 6.5: 2.5 to 3.5: 1 by weight, but not limited thereto, and when mixed in the above 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, The effect of improving wrinkles is superior to using alone or mixing in different weight ratios.
  • the cosmetic composition is characterized in that the noise is cited in the filamentous constitution, and whether or not the noise in the present invention is most preferably diagnosed by a medicinal doctor, the teacher is clinical character, body shape, physiology, pathology and mental psychology and According to the criteria classified as ideology, which is theorized by disease prevention, treatment and philosophy through the framework of four classifications (sun, lunar, literacy, noise) all over the universe, the noise person is short. He often walks in a poor and prone position, and his lower body is relatively developed, but overall he is dwarf, weak, and has a pretty face.
  • Kidneys and bladder function is good, but the stomach is weak because it does not digest food well.
  • the cosmetic composition is effective in preventing skin aging and improving skin wrinkles by inhibiting the expression of MMP-1.
  • the skin wrinkle improvement and anti-aging cosmetic composition is an external skin ointment, cream, supple cosmetics, nourishing cosmetics, packs, essences, hair tonic, shampoo, conditioner, hair conditioner, hair Treatment, Gel, Skin Lotion, Skin Softener, Skin Toner, Astringent, Lotion, Milk Lotion, Moisture Lotion, Nutrition Lotion, Massage Cream, Nutrition Cream, Moisture Cream, Hand Cream, Foundation, Nutrition Essence, Sunscreen, Soap, Cleansing It may have any one formulation selected from the group consisting of foam, cleansing lotion, cleansing cream, body lotion and body cleanser, but is not limited thereto.
  • the cosmetic composition consisting of each of these formulations may contain various bases and additives necessary for the formulation of the formulation and are suitable, and the type and amount of these components can be easily selected by those skilled in the art.
  • the carrier component is animal fiber, vegetable fiber, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide. And the like can be used.
  • the formulation of the cosmetic composition of the present invention is a powder or a spray
  • lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as the carrier component, and in particular, in the case of a spray, further chlorofluoro Propellants such as hydrocarbon, propane-butane or dimethyl ether.
  • a solvent, solvating agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene.
  • a carrier component such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene.
  • the formulation of the cosmetic composition of the present invention is a suspension
  • a liquid diluent such as water, ethanol or propylene glycol
  • suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.
  • the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, acethionate, an imidazolinium derivative, a methyltaurate, or a sarcosinate.
  • Fatty acid amide ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
  • the cosmetic composition of the present invention may further contain an excipient including a fluorescent substance, a fungicide, a caustic agent, a moisturizer, a fragrance, a fragrance carrier, a protein, a solubilizer, a sugar derivative, a sunscreen agent, a vitamin, a plant extract, and the like.
  • an excipient including a fluorescent substance, a fungicide, a caustic agent, a moisturizer, a fragrance, a fragrance carrier, a protein, a solubilizer, a sugar derivative, a sunscreen agent, a vitamin, a plant extract, and the like.
  • the present invention relates to a functional food composition for skin wrinkle improvement and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
  • the mixing ratio of the ginger, creation, turmeric and broiler extract is preferably 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, more preferably 1: 2.5 to 3.5: 5.5 to 6.5: 1 or 1: 5.5 to 6.5 It is a weight ratio of 1: 2.5 to 3.5: 1, and most preferably 1: 5.5 to 6.5: 2.5 to 3.5: 1, but it is not limited thereto, and it is characterized by being a noise cited among filamentous constitutions.
  • the health functional food composition of the present invention When used as a food additive, the health functional food composition may be added as it is or used with other foods or food ingredients, and may be appropriately used according to a conventional method. Mixed amounts of active ingredients may be suitably used depending on the purpose of use (prevention or improvement).
  • the nutraceutical composition of the present invention is added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less with respect to the raw material.
  • the amount may be below the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
  • dietary supplement there is no particular limitation on the type of dietary supplement.
  • foods to which the health functional food composition may be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products, including ice cream, various soups, drinks, tea Drinks, alcoholic beverages, vitamin complexes, and the like, and include all health foods in the conventional sense.
  • the nutraceutical composition of the present invention may be prepared as a food, in particular a functional food.
  • Functional foods of the present invention include ingredients that are commonly added in food production, and include, for example, proteins, carbohydrates, fats, nutrients and seasonings.
  • natural carbohydrates or flavors may be included as additional ingredients in addition to the active ingredient.
  • the natural carbohydrates may be monosaccharides (e.g. glucose, fructose, etc.), disaccharides (e.g.
  • the flavourant may be a natural flavourant (eg, taumartin, stevia extract, etc.) and a synthetic flavourant (eg, saccharin, aspartame, etc.).
  • the carbonation agent etc. which are used for a drink can be contained further.
  • the ratio of the above-mentioned ingredients is not critical, it is generally selected from 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food composition of the present invention.
  • the present invention relates to a pharmaceutical composition for preventing and treating skin wrinkles, which contains ginger, extract, turmeric and broiler mixed extract as active ingredients.
  • the mixing ratio of the ginger, creation, turmeric and broiler extract is preferably 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, but is not limited thereto, and is characterized by noise citation in filamentous constitution.
  • the pharmaceutical composition of the present invention may include a pharmaceutically acceptable carrier in addition to the active ingredient, which is commonly used in the preparation of lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, Calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and minerals Oils and the like, but are not limited thereto.
  • a pharmaceutically acceptable carrier in addition to the active ingredient, which is commonly used in the preparation of lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, Calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, prop
  • the pharmaceutical composition of the present invention may further include a lubricant, a humectant, a sweetener, a flavoring agent, an emulsifier, a suspending agent, a preservative, and the like.
  • a lubricant e.g., talc, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, kaolin, a kaolin, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, sorbitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mannitol, mann
  • Suitable dosages of the pharmaceutical compositions according to the present invention vary depending on factors such as the formulation method, mode of administration, age, weight, sex, morbidity, food, time of administration, route of administration, rate of excretion and response to response of the patient. Can be. On the other hand, the dosage of the pharmaceutical composition of the present invention is preferably 0.0001 to 100 mg / kg (body weight) per day.
  • the pharmaceutical composition of the present invention can be administered orally or parenterally, and in the case of parenteral administration, it can be administered topically to the skin, intravenous injection, subcutaneous injection, intramuscular injection, intraperitoneal injection, transdermal administration and the like.
  • the concentration of the active ingredient included in the pharmaceutical composition of the present invention can be determined in consideration of the purpose of treatment, the condition of the patient, the period of time, etc., and is not limited to a specific range of concentration.
  • compositions of the present invention may be prepared in unit dosage form by formulating with a pharmaceutically acceptable carrier or excipient according to methods which can be easily carried out by those skilled in the art. It can be prepared by incorporation into a dose container.
  • the formulation may be prepared in any one formulation selected from injections, creams, patches, sprays, ointments, warnings, lotions, linings, pastas and cataplasmas, and may further include a dispersant or stabilizer. Can be.
  • Herbal medicine was purchased from OmniHub, and each sample was stored in a herbal storage refrigerator maintaining a temperature of 5.5 ⁇ 0.3 °C and humidity of 55 ⁇ 5%.
  • Ginger, creation, turmeric and broiler extracts were extracted by refluxing twice with reflux for 3 hours by adding water corresponding to 10 times the total weight of each of ginger, creation, turmeric and broilers. The extract was prepared by removing the solvent.
  • HaCaT cells human keratinocyte line
  • FBS fetal bovine serum
  • PS penicillin-streptomycin
  • DMEM Dulbecco's Modified Eagle Medium
  • the evaluation is performed on the skin safety through visual evaluation, skin wrinkle parameter measurement, questionnaire evaluation by the subject and observation and questionnaire at each time before and after use of the product (week 0 and week 4, 8, 12). It was.
  • the study recruited noisy women between the ages of 30 and 65 and recruited 22 noisy female subjects who met the subject selection criteria and did not meet the exclusion criteria. Their age ranged from 35 to 54 years (mean age: 45.2). ⁇ 5.2 years old).
  • Skin wrinkles are tested by dermapro dermatological research institutes who have started to produce wrinkles or who have already participated in this study. A participation agreement was written and the participants participated in the test.
  • BMI measurement Inbody 330, Biospace, Korea
  • body circumference measurement Inbody 330, Biospace, Korea
  • photography and Sasang Constitution Diagnosis Questionnaire Evaluation were conducted to determine the noise factor.
  • the noise factor was selected using (SCAT, Sasang Constitutional Analysis Tool).
  • the constitution was diagnosed through SCAT in the first filtered subjects, and the constitution factor, which is the noise according to the present invention, was selected.
  • the highest constitution value (max (TE, SE, SY)) and second highest constitution value (median (TE) SE, SY)) were selected in order of big difference, and 22 people (including one dropout) who were judged as noise noise were selected.
  • test site there are any abnormalities on the test site such as spots, acne, erythema, and capillary dilatation
  • Subjects should not mix with functional cosmetics or medicines other than the test product.
  • the basic cosmetics used outside the test product are only skins and lotions without functional ingredients. Sun cream products should be used when going out. At the time of visit (measurement), the visit was made without color makeup.
  • the number of subjects was tested by selecting 20 or more subjects according to guidelines for evaluating the effectiveness of functional cosmetics (2003, 2005), and guidelines for test methods for cosmetic labeling and advertisement (2013).
  • Skin wrinkles were evaluated by analyzing skin replica images using Visioline® VL650 (C + K, Germany) at each time point.
  • the intensity of transmitted light varies depending on the thickness of the replica according to the shape of the skin.
  • R1 is the difference between the highest peak and the lowest valley of the wrinkle profile, and R2 equals five wrinkle profiles to get five R1 values, which is the largest of them.
  • R3 is an arithmetic mean of five consecutive R1 values by equalizing five wrinkle profiles, resulting in the removal of artifacts compared to R1 and R2.
  • R1, R2, and R3 can be understood as values representing the depth of wrinkles.
  • R4 is the average depth of skin wrinkles by drawing the horizontal line at the top of the profile and integrating the area with the profile divided by the length of the midline of the profile.
  • R5 is the mean roughness of the skin divided by the length of the midline of the profile by integrating the area between the midline of the profile and the profile (FIG. 3).
  • facial left and right sides were photographed using a facial skin imaging device (VISIA® CR, Canfield, USA).
  • VISIA® CR facial skin imaging device
  • the questionnaire about the efficacy of the product was conducted by the subject at the 4, 8, and 12 weeks of product use. The subjects were assessed at the 5-point scale (1, not at all; 2, not at all; 3. no difference; 5. Very much). In addition, the questionnaire on product usability was assessed on a five-level scale (1, not at all; 2, not good; 3, moderate; 4, good; 5, very good) at the time of evaluation 12 weeks after product use. The positive responses (4, good; 5, very good) written by the subjects were analyzed.
  • ginger, creation, turmeric and broiler extracts were prepared, and the weight ratio of ginger: creation: turmeric: chicken was 1: 1: 1: 1, 1: 2: 2: 1,1
  • the mixed extracts were prepared by mixing 1: 3: 3: 1, 1: 3: 6: 1, 1: 6: 3: 1.
  • the cell viability and MMP-1 expression levels were analyzed using the mixed extract prepared in Example 1, and the most effective mixed extract was selected to analyze the wrinkle improvement effect on 21 people with noise.
  • Example 1 The weight ratio of 1: 1: 1: 1: 1, 1: 2: 2: 1, 1: 3: 3: 1, 1: 3: 6: 1 and 1: 6: 3: 1 prepared in Example 1
  • the mixed ginger, extract, turmeric, and broiler mixed extracts were treated with HaCaT cells (human keratinocyte line) for 24 hours, irradiated with ultraviolet (UV Crosslinker, Ultra Lum) for 30 minutes, and then subjected to MTS assay.
  • HaCaT cells human keratinocyte line
  • UV Crosslinker, Ultra Lum ultraviolet
  • the cell survival rate was different according to the mixing ratio of the ginger, the production, turmeric and broiler mixture extract, the cell survival was reduced to 51.09% by UV irradiation, the mixing ratio 1: 6: 3:
  • the cell survival rate was 74.85% when treated with 50 ⁇ g / ml of ginger, production, turmeric and broiler mixed extract of 1, and the cell survival rate was 80.99% when treated with 100 ⁇ g / ml.
  • the cell survival rate was 93.93% when treated with ginger, production, turmeric and broiler extracts 3: 3: 1, and the cell viability was 94.11 when treated with 100 ⁇ g / ml. Appeared in%.
  • MMPs Collagen degrading enzymes
  • Example 3 the effect of improving wrinkles of a mixture of ginger, creation, turmeric and broiler extracts, which are active ingredients of the present invention, was analyzed by analyzing the change in the expression level of collagen degrading enzymes (MMPs; matrix metalloproteinases), which have a significant effect on collagen reduction Check whether there is.
  • MMPs collagen degrading enzymes
  • the expression level of MMP-1 was very low in the cells not irradiated with ultraviolet rays, it was confirmed that the expression of MMP-1 was significantly increased by ultraviolet irradiation.
  • the expression level (ng / ml) of MMP-1 was significantly reduced compared to the case of ultraviolet irradiation.
  • ginger, extract, turmeric and broiler extracts are mixed at a weight ratio of 1: 6: 3: 1, by confirming that the expression level of MMP-1 is very low, it is determined that the active ingredient of the present invention is effective in improving wrinkles. It was.
  • Example 4 based on the results of Examples 2 and 3, to prepare a test product containing a mixture of ginger, creation, turmeric and broiler mixed extract in a weight ratio of 1: 6: 3: 1, the most effective We conducted a clinical trial that applied it to 21 noisy patients.
  • Group 21 is a test group containing ginger, extract, turmeric and broiler mixed extract of 1: 6: 3: 1, which is an active ingredient of the present invention
  • group B is a control group that does not contain the active ingredient of the present invention.
  • Tables 2 to 4 below disclose information, skin types and skin conditions of test groups (A) and control groups (B) participating in clinical trials.
  • the skin of the test group and the control group was visually analyzed using RM ANOVA before, after 4 weeks, after 8 weeks, and after 12 weeks of application.
  • p value is less than 0.05, which means that there is a significant difference between the test group and the control group.

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Birds (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition for skin wrinkle reduction and anti-aging, containing, as an active ingredient, a mixture of extracts of ginger, Atractylodes lancea, Curcuma longa and Cinnamomum cassia and, specifically, a mixture of extracts, obtained by mixing the extracts of ginger, Atractylodes lancea, Curcuma longa and Cinnamomum cassia in a ratio of 1 : 2.5-6.5 : 2.5-6.5 : 1 by weight, inhibits cell damage caused by UV radiation and remarkably inhibits the expression of MMP-1. The composition of the present invention can be used as cosmetics, dietary supplements and pharmaceutical compositions and, particularly, has a remarkable skin wrinkle reduction effect on soeum type among sasang constitutions classified in traditional Korean medicine.

Description

한약재 혼합 추출물을 유효성분으로 함유하는 피부 노화 및 주름 개선용 조성물Composition for improving skin aging and wrinkles containing herbal extract as an active ingredient
본 발명은 한약재 혼합 추출물을 유효성분으로 함유하는 피부 노화 및 주름 개선용 조성물에 관한 것으로, 상세하게는 1:3~6:6~3:1의 중량비로 혼합한 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 노화 및 주름개선용 조성물에 관한 것이다. The present invention relates to a composition for improving skin aging and wrinkles, which contains a herb extract as an active ingredient, and specifically, a ginger mixed with a weight ratio of 1: 3 to 6: 6 to 3: 1, creation, turmeric and broiler mixture. It relates to a skin aging and wrinkle improvement composition containing the extract as an active ingredient.
피부는 외부환경의 자극으로부터 체내의 기관들을 보호해주며, 체온조절 등의 생체 항상성 유지에 중요한 역할을 한다. 이러한 피부는 여러 가지 내외적 요인에 의해서 노화가 발생하며, 크게 유전적 원인에 의한 내인성 노화와 환경적 원인에 의한 외인성 노화로 구분된다. 이 중, 광노화는 자외선(ultraviolet; UV)에 의한 노화를 의미한다. 최근 환경오염으로 인한 오존층 파괴는 자외선의 양을 증가시켰고 이에 따라 광노화에 대한 연구가 주목되고 있다(Wang SQ et al., 2010, Dermatol. Ther. 23(1):31-47). 광노화 된 피부에서는 거칠어짐, 탄력 손실, 주름 발생 및 불규칙한 색소 침착 등과 같은 외관상의 특징이 관찰되며, 이 중 광노화의 주된 연구 분야는 피부 주름의 변화에 대한 것이다. 상기 광노화에 의한 피부 주름 형성에 관해 피부의 주요 구성성분인 콜라겐(collagen)의 합성, 분해 및 수분 함유량 등의 기초적인 생리 대사 변화에 대한 연구 결과가 다수 보고되고 있다(Brenneisen et al., 2002, Ann. N. Y. Acad. Sci., 973:31-43). 특히 자외선에 의해 활성 산소종(reactive oxygen species) 생성이 증가되고 피부의 효소적, 비효소적 항산화 방어체계가 붕괴되어 콜라겐의 분해 증가 및 생합성을 감소시켜 진피층 내의 콜라겐이 현저하게 감소된다(Bickers DR, Athar M, 2006, J. Invest. Dermatol., 126(12):2565-2575). 상기 콜라겐 감소에 중요한 영향을 미치는 것은 콜라겐 분해 효소(MMPs; matrix metalloproteinases)로, 이는 세포외기질(extracellular matrix)과 기저막(basement membrane)의 분해에 관여한다. 상기 효소는 자외선에 의해 활성이 증가되며 이를 억제함으로써 자외선에 의해 유도되는 피부 두께 증가 및 주름 형성이 감소된다는 연구 결과들이 보고되어 있다(Inomata S et al., 2003, J. Invest. Dermatol., 120(1):128-134). 따라서 광노화의 예방 및 치료를 위해서는 MMPs를 조절하는 것이 효과적인 방법으로 알려져 있다.The skin protects the organs of the body from stimulation of the external environment and plays an important role in maintaining homeostasis such as temperature control. The skin is aged by various internal and external factors, and is classified into endogenous aging due to genetic causes and exogenous aging due to environmental causes. Among these, photoaging means aging by ultraviolet (UV). Recently, ozone layer destruction due to environmental pollution has increased the amount of ultraviolet rays, and thus, research on photoaging has been focused (Wang SQ et al., 2010, Dermatol. Ther. 23 (1): 31-47). In photo-aged skin, cosmetic features such as roughness, loss of elasticity, wrinkles and irregular pigmentation are observed. Among them, the main research field of photo-aging is about the change of skin wrinkles. A number of studies have been reported on basic physiological metabolic changes such as collagen, a major component of skin, and water content, regarding the formation of skin wrinkles by photoaging (Brenneisen et al., 2002, Ann.NY Acad. Sci., 973: 31-43). In particular, UV radiation increases the production of reactive oxygen species and disrupts the enzymatic and non-enzymatic antioxidant defenses of the skin, leading to increased collagen degradation and biosynthesis, which significantly reduces collagen in the dermal layer (Bickers DR , Athar M, 2006, J. Invest.Dermatol., 126 (12): 2565-2575). Significant effects on collagen reduction are collagen degrading enzymes (MMPs), which are involved in the degradation of extracellular matrix and basement membrane. It has been reported that the enzyme increases the activity by ultraviolet light and inhibits the increase in skin thickness and wrinkle formation induced by ultraviolet light (Inomata S et al., 2003, J. Invest. Dermatol., 120 (1): 128-134). Therefore, it is known to control MMPs for the prevention and treatment of photoaging.
한편, 생강(Zingiber officinale)은 특유의 향기와 매운맛 때문에 가정에서 식품원료인 향신료로 사용되어 왔으며, 다양한 활성 때문에 모든 한방 처방에 많이 사용되고 있다. 한약재의 원료로는 사용방법이 다양하며, 수확한 근경을 생강이라고 하며 생강의 근강을 찌거나 삶아서 건조한 것을 건강(乾薑)이라 하고, 불에 구워 말린 것을 흑강이라 칭한다. 생강은 소화액을 분비하여 식욕을 증진시키고 위장의 운동을 촉진하고 소화흡수를 도와주며, 또한 담을 없애고 기를 내리며 구토를 그치게 하고 풍한과 종기를 제거함과 동시에 천식에 사용된다(신민교. 임상본초학(Clinical Traditional Herbalogy), 영림사, 1997, 293-296; 이상인, 본초학, 1981, 203-204). 또한 발한 해열약, 혈행장애, 감기풍한 등에 이용되고 있으며 방향신미 성분은 혈액순환과 체온을 증가시키며, 민간요법으로 감기와 기침을 치료하기 위해 생강즙에 꿀을 혼합하여 복용한다. 반면에 건강은 신진대사 기능이 저하되었을 때 이용되며 기침, 현기증, 손발이 찬 경우, 요통, 설사, 구토 등의 치료제로 활용된다. 또한, 구풍, 소화제로서 심기를 통하고 양을 돋우며 오장육부의 냉을 제거하는데 사용된다.On the other hand, ginger (Zingiber officinale) has been used as a food ingredient in the home because of its unique aroma and spicy, it is used a lot in all herbal prescriptions because of its various activities. The raw materials of Chinese herbal medicines are used in various ways. The harvested rhizome is called ginger, and the steamed or boiled ginger dried is called health (乾薑), and the roasted and dried is called black river. Ginger secretes digestive juices to promote appetite, promote gastrointestinal motility, aid in digestion and absorption, and is also used for asthma at the same time as it eliminates phlegm, lowers energy, stops vomiting, removes cold and boils (Clinical Traditional) Herbalogy, Younglimsa, 1997, 293-296; and above, Herbal Science, 1981, 203-204). It is also used for antipyretic drugs, blood circulation disorders, cold and cold. Aromatherapy ingredients increase blood circulation and body temperature, and take honey mixed with ginger juice to treat colds and coughs. On the other hand, health is used when metabolic function is lowered and is used as a treatment for cough, dizziness, cold hands and feet, low back pain, diarrhea and vomiting. It is also used for planting, boosting sheep and removing cold of five viscera.
또한, 창출(Atractylodes lancea)은 중국의 화북, 산서 등에 분포하는 국화(Compositae)과 식물인 삽주 속의 뿌리줄기로서 길이 3~10㎝, 지름 10~25㎜의 불규칙하게 구부러진 원주형으로 바깥면은 어두운 회분비물에 의한 가는 점이 있으며, 약리작용으로 건위작용, 이뇨작용, 발한작용, 진정작용, 혈당저하작용, 강장작용 등이 있는 것으로 알려져 있다. 창출은 다년생 초본으로 각지의 산에 자라며, 가을에 캐서 물에 씻어 잔뿌리를 다듬고 햇볕에 말린 것이다. 창출에는 약 1.5%의 정유와 카로틴, 이눌린, 고무질, 알카로이드 반응이 있고, 전초는 사포닌, 쿠마린 반응이 있다. 창출은 달고 맵고 따뜻하여 진정작용, 조혈작용, 오줌내기작용이 있으며, 동의치료에서는 실증에 의한 콩팥 기능장애로 오줌이 적을 때, 위장염, 붓기, 어지럼증과 온몸이 아플 때 오줌내기, 땀내기 약 등으로 동의처방에 배합하는 매우 중요한 약재이다.In addition, Atractylodes lancea ) is a root stem in the genus (Compositae) and plant, which is distributed in North China, Shanxi, etc., and is irregularly bent cylindrical shape of 3 ~ 10cm long and 10 ~ 25mm in diameter, and the outer surface is made by dark ash. There is a point, pharmacological action is known to have a healthy, diuretic, sweating, sedative, hypoglycemic, tonic action. Creation is a perennial herb, which grows in mountains all over the country. In the fall, it is cut and washed in water to trim fine roots and to dry in the sun. There are about 1.5% essential oils, carotene, inulin, gum and alkaloid reactions, and outposts have saponin and coumarin reactions. It is sweet and spicy, warm and has sedation, hematopoiesis, and urinary action.In motion therapy, when the urine is low due to renal dysfunction caused by emphysema, gastroenteritis, swelling, dizziness and peeing when the whole body hurts, sweating medicine, etc. It is a very important medicine that is formulated in agreement.
또한, 강황(Curcuma longa)은 편자강황이라고도 하며, 우리나라의 중부 이남에서 재배되며, 가을에 뿌리줄기를 캐 물에 씻어 삶거나 쪄서 말린다. 맛은 맵고, 쓰며 성질은 매우 따뜻하다. 기와 혈액순환을 촉진하며 어혈을 없애며, 통증을 멎게 하고 월경을 순조롭게 한다. 약리실험에서 이담작용, 간의 해독 기능을 높이는 작용 진통작용, 자궁수축작용 항균 작용 등이 알려져 있다. 무월경, 기혈이 막혀 가슴과 배가 아픈 데, 팔이 쑤시는 데, 간염, 담석증, 타박상 옹종 등에 사용한다. Curcuma longa , also known as horseshoe turmeric, is cultivated in the sub-central part of Korea, and the roots are washed in water in autumn and boiled or steamed to dry. The taste is spicy, bitter and very warm. Promotes circulation and blood circulation, eliminates blood, eases pain and smoothes menstruation. In pharmacological experiments, it has been known that biliary tract function, liver detoxification function, analgesic action, uterine contraction action antibacterial action. It is used for amenorrhea, bleeding, and chest and stomach aches, swelling of arms, hepatitis, cholelithiasis, and bruising carbuncles.
또한, 육계(Cinnamomum cassia)는 지역에 따라 기원식물이 다를 수 있고, 그 질도 다를 수 있다. 그 채취 연한과 가공방법이 지역에 따라 다르기 때문에 상품 규격도 기변계, 관계, 판계, 계심, 계쇄 등 종류가 비교적 많다. 줄기껍질로 통 모양 또는 말려 들어간 통 모양이고, 길이 5~50cm, 지름 1.5~5cm, 두께 0.1~0.5cm이다. 바깥 면은 어두운 적갈색, 안쪽 면은 적갈색을 띠며 매끈하다. 꺾이기 쉬우며 꺾인 면은 적갈색을 띠고 연한 갈색의 얇은 층이 있으며 약간 섬유성이다. 특유한 냄새가 있으며 맛은 약간 달고 매우며 후에 약간 점액성이고 수렴성이다.In addition, broilers ( Cinnamomum cassia ) may have different plant origins and different qualities depending on the region. Since the sampling age and processing method differ from region to region, product specifications also include relatively many types such as variometers, relations, plates, chains, and chains. It is tubular or rolled into stem shell, 5 ~ 50cm long, 1.5 ~ 5cm in diameter, and 0.1 ~ 0.5cm thick. The outer side is dark reddish brown and the inner side is reddish brown and smooth. It is easy to bend and its face is reddish brown with a thin layer of light brown color and slightly fibrous. It has a peculiar smell, tastes slightly sweet and very, later slightly mucus and astringent.
한편, 사상의학은 이제마 선생이 임상관찰을 통하여 성격, 체형, 생리, 병리 외형과 정신 심리 및 전 우주에 이르기까지 4가지 분류라는 틀을 통하여 인식하였고 이것을 질병의 예방, 치료 및 철학으로 이론화 체계화하였다. 사상의학에서는 체질은 한 번 타고나면 불변하는 것으로 보며, 특질이나 기질, 성격 적성 등을 결정하는 특성에 따라 태양인, 태음인, 소양인, 소음인의 4가지 타입으로 분류하고, 각기 체질에 따른 음식과 섭생 등으로 질병을 미리 예방할 수도 있고 병이 났을 때는 각자의 체질에 따라 치료법이 다르다. 따라서 같은 화장품, 식품 또는 약물일지라도 체질에 따라 유익할 수 있고 해로울 수도 있는 것이다. On the other hand, ideology has been recognized through the four categories of personality, body type, physiology, pathology, mental psychology, and the entire universe through clinical observation. . In ideology, constitution is considered to be immutable once innate, and classified into four types of sun person, Taein person, Soyangin, and noise person according to the characteristics that determine characteristics, temperament, and personality aptitude. The disease can be prevented in advance, or when you get sick, depending on their constitution, the treatment is different. Therefore, even the same cosmetics, food or drugs may be beneficial or harmful depending on the constitution.
이러한 사상체질 중에서 소음인은 본래 비장과 위장이 허약하고 신장이 충실하기 때문에 몸의 형태가 위아래로 균형이 잘 잡혀져 있고, 생김새는 일반적으로 작은 편이나 혹 장대한 사람도 있다. 여자는 용모가 잘 짜여져 있어 오밀조밀하고 깜찍하며 또 애교가 넘친다. 이마가 약간 나오고 눈·코·입이 크지 않으며 눈에는 정기가 어려 흡수적(吸收的)이라 할 수 있다. 피부는 매우 부드럽고 치밀하여 땀이 적으며, 여자는 겨울철에 물 일을 해도 손이 트지 않는다.Among these Sasang constitution, the noise person is weak in spleen and stomach, and the kidney is faithful, so the shape of the body is well-balanced up and down. The woman is well-framed, dense, cute and charming. Forehead comes out a little, eyes, nose, mouth is not big, and the eyes are young and regular (이라 的) can be called. The skin is so soft and dense that there is little sweat, and a woman does not lose her hands even when working in winter.
상기 생강, 창출, 강황 및 육계 혼합 추출물과 피부의 주름 개선 또는 피부노화 관련 기술로 알려진 일례로는 한국등록특허 제1182765호에 항산화 및 항노화 효과를 가지는 산물진피 및 생강 혼합 추출물을 포함하는 화장료 조성물 및 그 제조방법이 알려져 있고, 한국공개특허 제2008-0094457호에 주름개선용 화장료 조성물이 알려져 있으며, 한국공개특허 제2001-0055960호에 육계추출물을 함유하는 화장료 조성물이 알려져 있고, 한국등록특허 제0891986호에 생약 추출물과 생약 분말을 함유하는 한방 화장료 조성물에 대하여 개시되어 있으나, 본 발명의 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 화장료 조성물에 대해서는 언급된 바 없다. Examples of known ginger, creation, turmeric and broiler mixed extract and skin wrinkle improvement or skin aging related technology cosmetic composition comprising a product dermis and ginger mixed extract having antioxidant and anti-aging effects in Korean Patent No. 1118765 And a method of manufacturing the same, a cosmetic composition for improving wrinkles is known from Korean Patent Publication No. 2008-0094457, and a cosmetic composition containing broiler extract is disclosed in Korean Patent Publication No. 2001-0055960. 0891986 discloses a herbal cosmetic composition containing a herbal extract and a herbal powder, but it is mentioned with respect to the cosmetic composition for skin wrinkle improvement and anti-aging containing the ginger, creation, turmeric and broiler mixed extract of the present invention as an active ingredient No bar
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 생강(Zingiber officinale), 창출(Atractylodes lancea), 강황(Curcuma longa) 및 육계(Cinnamomum cassia) 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 조성물에 관한 것으로, 상세하게는 생강, 창출, 강황 및 육계 추출물을 1:2.5~6.5:2.5~6.5:1 중량비로 혼합한 혼합추출물은 자외선 조사에 의한 세포 손상을 억제하며, MMP-1의 발현을 현저하게 억제하고, 특히 소음인에게 주름개선 효과가 있다는 것을 확인함으로써, 본 발명을 완성하였다.The present invention is derived from the above demands, ginger ( Zingiber officinale), Creation ( Atractylodes) lancea ), Curcuma Longa ) and Cinnamomum cassia ( Cinnamomum cassia ) relates to a composition for improving skin wrinkles and anti-aging containing the extract as an active ingredient, in particular ginger, creation, turmeric and broiler extract 1: 2.5 ~ 6.5: 2.5 ~ 6.5: 1 The mixed extract mixed in a weight ratio suppresses cellular damage by ultraviolet irradiation, significantly suppresses the expression of MMP-1, and in particular, confirms that there is an antiwrinkle effect on the noise person, thereby completing the present invention.
상기 목적을 달성하기 위하여, 본 발명은 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 화장료 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic composition for skin wrinkle improvement and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
또한, 본 발명은 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 건강기능식품 조성물을 제공한다.The present invention also provides a functional food composition for improving skin wrinkles and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
또한, 본 발명은 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 예방 및 치료용 약학 조성물을 제공한다.In another aspect, the present invention provides a pharmaceutical composition for preventing and treating skin wrinkles containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
본 발명은 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 조성물에 관한 것으로, 상세하게는 생강, 창출, 강황 및 육계 추출물을 1:2.5~6.5:2.5~6.5:1 중량비로 혼합한 혼합추출물은 자외선 조사에 의한 세포 손상을 억제하며, MMP-1의 발현을 현저하게 억제한다. 생강, 창출, 강황 및 육계 추출물의 혼합비가 1:2.5~6.5:2.5~6.5:1 중량비인 경우, 다른 혼합비로 혼합하거나, 생강, 창출, 강황 또는 육계 추출물을 단독으로 사용하는 경우보다 효과적으로 자외선 조사에 의한 세포 손상을 억제하며, MMP-1의 발현을 현저하게 억제하는 것이다. 본 발명의 유효성분은 한의학에서 분류하는 사상체질 중 소음인에게 피부 주름 개선 효과가 탁월한 효과가 있는 것으로 소음인의 화장료 조성물, 건강기능식품 조성물 및 약학 조성물로 유용하게 사용할 수 있다. The present invention relates to a composition for improving skin wrinkles and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient, in detail, the ginger, creation, turmeric and broiler extract 1: 2.5 ~ 6.5: 2.5 ~ 6.5 Mixed extracts mixed at a weight ratio of 1 to 1 inhibit cellular damage by UV irradiation and significantly inhibit the expression of MMP-1. When the blending ratio of ginger, crude, turmeric and broiler extracts is 1: 2.5 to 6.5: 2.5 to 6.5: 1 by weight, it is more effective to irradiate with ultraviolet rays than to mix with other blending ratios or to use ginger, crude, turmeric or broiler extracts alone. It suppresses cellular damage by and significantly suppresses the expression of MMP-1. The active ingredient of the present invention is effective to improve the skin wrinkles to the noise person in the Sasang constitution classified in the oriental medicine can be usefully used as a cosmetic composition, health functional food composition and pharmaceutical composition of the noise person.
도 1은 본 발명의 생강, 창출, 강황 및 육계 혼합 추출물의 혼합비(중량비에 따른 혼합)별 세포 생존률을 확인하기 위하여, HaCaT 세포(사람 각질형성 세포주)에 24시간 동안 각각의 시료를 농도별(50㎍/㎖ 및 100㎍/㎖)로 처리하고, 자외선(UV Crosslinker, UltR5 Lum)을 30분간 조사한 후, MTS 어세이를 수행한 결과이다.1 is a concentration of each sample for 24 hours in HaCaT cells (human keratinocytes) in order to determine the cell survival rate by the mixing ratio (mixing according to the weight ratio) of ginger, creation, turmeric and broiler mixed extract of the present invention ( 50 μg / ml and 100 μg / ml), irradiated with ultraviolet (UV Crosslinker, UltR5 Lum) for 30 minutes, followed by an MTS assay.
도 2는 본 발명의 생강, 창출, 강황 및 육계 혼합 추출물의 혼합비(중량비에 따른 혼합)별 MMP-1의 발현량을 확인한 결과이다.Figure 2 is a result confirming the expression amount of MMP-1 by the mixing ratio (mixing according to the weight ratio) of the ginger, creation, turmeric and broiler mixed extract of the present invention.
도 3은 레플리카 분석에서 사용되는 주름 파라미터의 정의 및 다이어그램이다.3 is a definition and diagram of the wrinkle parameters used in replica analysis.
도 4는 중량비가 1:6:3:1의 중량비로 혼합된 생강, 창출, 강황 및 육계 혼합 추출물을 함유하는 제품을 사용한 시험군과 대조군 사이의 주름 개선 효과를 레플리카의 R1 파라미터의 분석 결과이다. (A)는 제품의 사용하기 전(0W), 사용 4주 후(4W), 사용 8주 후(8W) 및 사용 12주 후(12W)에 측정된 R1 값을 나타낸 것이며, (B)는 사용 전(0W)을 기준으로 했을 때, R1의 변화율을 나타낸 것이다. *는 본 발명에 따른 제품을 사용하기 전(0주)과 비교하여 통계적으로 유의한 차이가 있다는 것을 의미하며, †는 시험군과 대조군에서 차이가 통계적으로 유의한 차이가 있다는 것을 의미한다, *와 †는 p값이 0.05 미만임을 나타낸다. Figure 4 is a result of the analysis of the R1 parameter of the replica wrinkle effect between the test group and the control group using a product containing ginger, the production, turmeric and broiler mixed extract in a weight ratio of 1: 6: 3: 1 . (A) shows R1 values measured before use (0W), after 4 weeks of use (4W), after 8 weeks of use (8W) and after 12 weeks of use (12W). The change rate of R1 is shown based on the previous (0W). * Means that there is a statistically significant difference compared to before using the product according to the present invention (week 0), † means that there is a statistically significant difference between the test group and the control group, * And † indicate that the p value is less than 0.05.
도 5는 중량비가 1:6:3:1의 중량비로 혼합된 생강, 창출, 강황 및 육계 혼합 추출물을 함유하는 제품을 사용한 시험군과 대조군 사이의 주름 개선 효과를 레플리카의 R4 파라미터의 분석 결과이다. (A)는 제품의 사용하기 전(0W), 사용 4주 후(4W), 사용 8주 후(8W) 및 사용 12주 후(12W)에 측정된 R4 값을 나타낸 것이며, (B)는 사용 전(0W)을 기준으로 했을 때, R4의 변화율을 나타낸 것이다. Figure 5 is a result of the analysis of the R4 parameter of the replica wrinkle effect between the test group and the control group using a product containing ginger, the production, turmeric and broiler mixed extract in a weight ratio of 1: 6: 3: 1 . (A) shows R4 values measured before use (0W), after 4 weeks of use (4W), after 8 weeks of use (8W) and after 12 weeks of use (12W). The change rate of R4 is shown based on the previous (0W).
*는 본 발명에 따른 제품을 사용하기 전(0주)과 비교하여 통계적으로 유의한 차이가 있다는 것을 의미하며, †는 시험군과 대조군에서 차이가 통계적으로 유의한 차이가 있다는 것을 의미한다, *와 †는 p값이 0.05 미만임을 나타낸다. * Means that there is a statistically significant difference compared to before using the product according to the present invention (week 0), † means that there is a statistically significant difference between the test group and the control group, * And † indicate that the p value is less than 0.05.
본 발명은 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for improving skin wrinkles and anti-aging containing ginger, extract, turmeric and broiler mixed extract as an active ingredient.
상기 생강, 창출, 강황 및 육계 추출물은 물, C1~C4의 저급알코올, 프로필렌글리콜, 에틸아세트산, 부틸렌글리콜, 글리세린, 에테르 및 클로로포름 중에서 선택된 하나 이상의 용매를 이용하여 추출한 것이 바람직하고, 더 바람직하게는 열수 추출하는 것이나, 이에 한정하지 않는다. The ginger, creation, turmeric and broiler extract is preferably extracted using at least one solvent selected from water, C 1 ~ C 4 lower alcohol, propylene glycol, ethyl acetate, butylene glycol, glycerin, ether and chloroform, more Preferably hot water extraction is not limited to this.
상기 생강, 창출, 강황 및 육계 추출물의 혼합비는 1:2.5~6.5:2.5~6.5:1 중량비인 것이 바람직하며, 더욱 바람직하게는 1:2.5~3.5:5.5~6.5:1 또는 1:5.5~6.5:2.5~3.5:1 중량비이고, 가장 바람직하게는 1:5.5~6.5:2.5~3.5:1 중량비지만, 이에 한정하지 않으며, 상기 1:2.5~6.5:2.5~6.5:1 중량비로 혼합하는 경우, 단독으로 사용하거나 또는 다른 중량비로 혼합하는 것에 비해 주름개선 효과가 탁월하다.  The mixing ratio of the ginger, creation, turmeric and broiler extract is preferably 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, more preferably 1: 2.5 to 3.5: 5.5 to 6.5: 1 or 1: 5.5 to 6.5 : 2.5 to 3.5: 1 by weight, most preferably 1: 5.5 to 6.5: 2.5 to 3.5: 1 by weight, but not limited thereto, and when mixed in the above 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, The effect of improving wrinkles is superior to using alone or mixing in different weight ratios.
상기 화장료 조성물은 사상체질 중에서 소음인용인 것을 특징으로 하며, 본 발명에서의 소음인 여부는 한의사에 의해 진단받는 것이 가장 바람직하며, 이제마 선생이 임상관찰을 통하여 성격, 체형, 생리, 병리 외형과 정신 심리 및 전 우주에 이르기까지 4가지 분류(태양, 태음, 소양, 소음)라는 틀을 통하여 질병 예방, 치료 및 철학으로 이론화 체계화한 사상의학으로 분류한 기준에 의거하여 소음인은 키가 작은 편이며, 상체가 빈약하여 수그린 자세로 걷는 경우가 많고, 비교적 하체가 발달한 편이지만, 전체적으로 왜소하고 약하고 얼굴이 오밀 조밀 예쁜 편이다. 여성적 성향이 강하며, 침착하고, 세심하게 신경 쓰고 챙기기를 잘하고, 생각이 많아 신중한 편으로 일을 빈틈없이 처리하는 성격이지만, 세심함과 신중함이 지나쳐서 소심할 수 있으며, 모험을 꺼리는 경향이 있고, 내성적이고, 이기심과 질투심이 많아 사소한 일에도 감정이 상하고 쉽게 풀어지지 않는다. 신장과 방광의 기능이 좋지만, 위의 기능이 약하여 음식을 잘 소화하지 못하는 체질이 있는 사람을 의미한다.The cosmetic composition is characterized in that the noise is cited in the filamentous constitution, and whether or not the noise in the present invention is most preferably diagnosed by a medicinal doctor, the teacher is clinical character, body shape, physiology, pathology and mental psychology and According to the criteria classified as ideology, which is theorized by disease prevention, treatment and philosophy through the framework of four classifications (sun, lunar, literacy, noise) all over the universe, the noise person is short. He often walks in a poor and prone position, and his lower body is relatively developed, but overall he is dwarf, weak, and has a pretty face. Strongly feminine, calm, attentive, well cared for, thoughtful and prudent, but attentive and discreet, too timid, adventurous, and introverted , Selfishness and jealousy a lot, even small things are hurt and not easily released. Kidneys and bladder function is good, but the stomach is weak because it does not digest food well.
상기 화장료 조성물은 MMP-1의 발현을 저해함으로써 피부의 노화 방지 및 피부 주름개선에 효과가 있는 것이다. The cosmetic composition is effective in preventing skin aging and improving skin wrinkles by inhibiting the expression of MMP-1.
본 발명의 일 구현 예에 따른 화장료 조성물에 있어서, 상기 피부 주름 개선 및 항노화용 화장료 조성물은 피부 외용 연고, 크림, 유연화장수, 영양화장수, 팩, 에센스, 헤어토닉, 샴푸, 린스, 헤어 컨디셔너, 헤어 트리트먼트, 젤, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 마사지 크림, 영양크림, 모이스처 크림, 핸드 크림, 파운데이션, 영양에센스, 선스크린, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디 로션 및 바디 클렌저로 이루어지는 군으로부터 선택된 어느 하나의 제형을 가질 수 있으나, 이에 제한되지 않는다. 이들 각 제형으로 이루어진 화장료 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다.In the cosmetic composition according to an embodiment of the present invention, the skin wrinkle improvement and anti-aging cosmetic composition is an external skin ointment, cream, supple cosmetics, nourishing cosmetics, packs, essences, hair tonic, shampoo, conditioner, hair conditioner, hair Treatment, Gel, Skin Lotion, Skin Softener, Skin Toner, Astringent, Lotion, Milk Lotion, Moisture Lotion, Nutrition Lotion, Massage Cream, Nutrition Cream, Moisture Cream, Hand Cream, Foundation, Nutrition Essence, Sunscreen, Soap, Cleansing It may have any one formulation selected from the group consisting of foam, cleansing lotion, cleansing cream, body lotion and body cleanser, but is not limited thereto. The cosmetic composition consisting of each of these formulations may contain various bases and additives necessary for the formulation of the formulation and are suitable, and the type and amount of these components can be easily selected by those skilled in the art.
본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a paste, cream or gel, the carrier component is animal fiber, vegetable fiber, wax, paraffin, starch, tragacanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide. And the like can be used.
본 발명의 화장료 조성물의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가로 클로로플루오로히드로카본, 프로판-부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.If the formulation of the cosmetic composition of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as the carrier component, and in particular, in the case of a spray, further chlorofluoro Propellants such as hydrocarbon, propane-butane or dimethyl ether.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene. Fatty acid esters of glycol, 1,3-butylglycol oil, glycerol aliphatic ester, polyethylene glycol or sorbitan.
본 발명의 화장료 조성물의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, suspending agents such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, Microcrystalline cellulose, aluminum metahydroxy, bentonite, agar or tracant and the like can be used.
본 발명의 화장료 조성물의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 아세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a surfactant-containing cleansing agent, the carrier component is an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, acethionate, an imidazolinium derivative, a methyltaurate, or a sarcosinate. Fatty acid amide ether sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, linolin derivatives or ethoxylated glycerol fatty acid esters and the like can be used.
본 발명의 화장료 조성물은 형광물질, 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain an excipient including a fluorescent substance, a fungicide, a caustic agent, a moisturizer, a fragrance, a fragrance carrier, a protein, a solubilizer, a sugar derivative, a sunscreen agent, a vitamin, a plant extract, and the like. .
또한, 본 발명은 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 건강기능식품 조성물에 관한 것이다.In addition, the present invention relates to a functional food composition for skin wrinkle improvement and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
상기 생강, 창출, 강황 및 육계 추출물의 혼합비는 1:2.5~6.5:2.5~6.5:1 중량비인 것이 바람직하며, 더욱 바람직하게는 1:2.5~3.5:5.5~6.5:1 또는 1:5.5~6.5:2.5~3.5:1의 중량비이고, 가장 바람직하게는 1:5.5~6.5:2.5~3.5:1 중량비지만, 이에 한정하지 않으며, 사상체질 중에서 소음인용인 것이 특징이다.  The mixing ratio of the ginger, creation, turmeric and broiler extract is preferably 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, more preferably 1: 2.5 to 3.5: 5.5 to 6.5: 1 or 1: 5.5 to 6.5 It is a weight ratio of 1: 2.5 to 3.5: 1, and most preferably 1: 5.5 to 6.5: 2.5 to 3.5: 1, but it is not limited thereto, and it is characterized by being a noise cited among filamentous constitutions.
본 발명의 건강기능식품 조성물을 식품첨가물로 사용하는 경우, 상기 건강기능식품 조성물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시 본 발명의 건강기능식품 조성물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나 건강을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로 사용될 수 있다.When the health functional food composition of the present invention is used as a food additive, the health functional food composition may be added as it is or used with other foods or food ingredients, and may be appropriately used according to a conventional method. Mixed amounts of active ingredients may be suitably used depending on the purpose of use (prevention or improvement). In general, in the preparation of food or beverages, the nutraceutical composition of the present invention is added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less with respect to the raw material. However, in the case of long-term intake for health purposes, the amount may be below the above range, and since there is no problem in terms of safety, the active ingredient may be used in an amount above the above range.
상기 건강기능식품의 종류에 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the type of dietary supplement. Examples of foods to which the health functional food composition may be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gums, dairy products, including ice cream, various soups, drinks, tea Drinks, alcoholic beverages, vitamin complexes, and the like, and include all health foods in the conventional sense.
또한, 본 발명의 건강기능식품 조성물은 식품, 특히 기능성 식품으로 제조될 수 있다. 본 발명의 기능성 식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등), 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다.In addition, the nutraceutical composition of the present invention may be prepared as a food, in particular a functional food. Functional foods of the present invention include ingredients that are commonly added in food production, and include, for example, proteins, carbohydrates, fats, nutrients and seasonings. For example, when prepared with a drink, natural carbohydrates or flavors may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates may be monosaccharides (e.g. glucose, fructose, etc.), disaccharides (e.g. maltose, sucrose, etc.), oligosaccharides, polysaccharides (e.g., dextrins, cyclodextrins, etc.), or sugar alcohols ( For example, xylitol, sorbitol, erythritol and the like) are preferable. The flavourant may be a natural flavourant (eg, taumartin, stevia extract, etc.) and a synthetic flavourant (eg, saccharin, aspartame, etc.).
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. 이러한 상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 조성물 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.Various nutritional supplements, vitamins, electrolytes, flavors, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloid thickeners, pH regulators, stabilizers, preservatives, glycerin, alcohols, carbonic acid The carbonation agent etc. which are used for a drink can be contained further. Although the ratio of the above-mentioned ingredients is not critical, it is generally selected from 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food composition of the present invention.
또한, 본 발명은 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 예방 및 치료용 약학 조성물에 관한 것이다. 상기 생강, 창출, 강황 및 육계 추출물의 혼합비는 1:2.5~6.5:2.5~6.5:1 중량비인 것이 바람직하지만 이에 한정하지 않으며, 사상체질 중에서 소음인용인 것이 특징이다.In addition, the present invention relates to a pharmaceutical composition for preventing and treating skin wrinkles, which contains ginger, extract, turmeric and broiler mixed extract as active ingredients. The mixing ratio of the ginger, creation, turmeric and broiler extract is preferably 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio, but is not limited thereto, and is characterized by noise citation in filamentous constitution.
본 발명의 약학 조성물은 유효성분 이외에 약학적으로 허용되는 담체를 포함할 수 있으며, 이러한 담체는 제제 시에 통상적으로 이용되는 것으로서, 락토스, 덱스트로스, 수크로스, 솔비톨, 만니톨, 전분, 아카시아 고무, 인산 칼슘, 알기네이트, 젤라틴, 규산 칼슘, 미세결정성 셀룰로스, 폴리비닐피롤리돈, 셀룰로스, 물, 시럽, 메틸 셀룰로스, 메틸히드록시벤조에이트, 프로필히드록시벤조에이트, 활석, 스테아르산 마그네슘 및 미네랄 오일 등을 포함하나, 이에 한정되는 것은 아니다. 본 발명의 약학적 조성물은 상기 성분들 이외에 윤활제, 습윤제, 감미제, 향미제, 유화제, 현탁제, 보존제 등을 추가로 포함할 수 있다. 적합한 약학적으로 허용되는 담체 및 제제는 레밍턴의 약학적 과학(Remington's Pharmaceutical Sciences, 19th ed., 1995)에 상세히 기재되어 있다.The pharmaceutical composition of the present invention may include a pharmaceutically acceptable carrier in addition to the active ingredient, which is commonly used in the preparation of lactose, dextrose, sucrose, sorbitol, mannitol, starch, acacia rubber, Calcium phosphate, alginate, gelatin, calcium silicate, microcrystalline cellulose, polyvinylpyrrolidone, cellulose, water, syrup, methyl cellulose, methylhydroxybenzoate, propylhydroxybenzoate, talc, magnesium stearate and minerals Oils and the like, but are not limited thereto. In addition to the above components, the pharmaceutical composition of the present invention may further include a lubricant, a humectant, a sweetener, a flavoring agent, an emulsifier, a suspending agent, a preservative, and the like. Suitable pharmaceutically acceptable carriers and formulations are described in detail in Remington's Pharmaceutical Sciences, 19th ed., 1995.
본 발명에 따른 약학 조성물의 적합한 투여량은 제제화 방법, 투여 방식, 환자의 연령, 체중, 성, 병적 상태, 음식, 투여 시간, 투여 경로, 배설 속도 및 반응 감응성과 같은 요인들에 의해 다양하게 처방될 수 있다. 한편, 본 발명의 약학 조성물의 투여량은 바람직하게는 1일 당 0.0001 내지 100mg/kg(체중)이다.Suitable dosages of the pharmaceutical compositions according to the present invention vary depending on factors such as the formulation method, mode of administration, age, weight, sex, morbidity, food, time of administration, route of administration, rate of excretion and response to response of the patient. Can be. On the other hand, the dosage of the pharmaceutical composition of the present invention is preferably 0.0001 to 100 mg / kg (body weight) per day.
본 발명의 약학 조성물은 경구 또는 비경구로 투여할 수 있으며, 비경구 투여의 경우, 피부에 국소적으로 도포, 정맥 내 주입, 피하 주입, 근육 주입, 복강 주입, 경피 투여 등으로 투여할 수 있다.The pharmaceutical composition of the present invention can be administered orally or parenterally, and in the case of parenteral administration, it can be administered topically to the skin, intravenous injection, subcutaneous injection, intramuscular injection, intraperitoneal injection, transdermal administration and the like.
본 발명의 약학 조성물에 포함되는 유효성분의 농도는 치료 목적, 환자의 상태, 필요기간 등을 고려하여 결정할 수 있으며 특정 범위의 농도로 한정되지 않는다.The concentration of the active ingredient included in the pharmaceutical composition of the present invention can be determined in consideration of the purpose of treatment, the condition of the patient, the period of time, etc., and is not limited to a specific range of concentration.
본 발명의 약학 조성물은 당해 발명이 속하는 기술분야에서 통상의 지식을 가진 자가 용이하게 실시할 수 있는 방법에 따라, 약학적으로 허용되는 담체 또는 부형제를 이용하여 제제화함으로써 단위 용량 형태로 제조되거나 또는 다용량 용기 내에 내입시켜 제조될 수 있다. 이때 제형은 주사제, 크림, 패취, 분무제, 연고제, 경고제, 로션제, 리니멘트제, 파스타제 및 카타플라스마제 중에서 선택된 어느 하나의 제형으로 제조될 수도 있으며, 분산제 또는 안정화제를 추가로 포함할 수 있다.The pharmaceutical compositions of the present invention may be prepared in unit dosage form by formulating with a pharmaceutically acceptable carrier or excipient according to methods which can be easily carried out by those skilled in the art. It can be prepared by incorporation into a dose container. In this case, the formulation may be prepared in any one formulation selected from injections, creams, patches, sprays, ointments, warnings, lotions, linings, pastas and cataplasmas, and may further include a dispersant or stabilizer. Can be.
이하, 실시예를 이용하여 본 발명을 더욱 상세하게 설명하고자 한다. 이들 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로 본 발명의 범위가 이들에 의해 제한되지 않는다는 것은 당해 기술분야에서 통상의 지식을 가진 자에게 있어 자명한 것이다. Hereinafter, the present invention will be described in more detail with reference to Examples. These examples are only for explaining the present invention in more detail, it is obvious to those skilled in the art that the scope of the present invention is not limited by them.
[재료 및 방법][Materials and methods]
1. 한약재 추출물의 제조1. Preparation of Herbal Extracts
한약재는 옴니허브로부터 구입하였고, 각 시료는 5.5±0.3℃의 온도 및 55±5%의 습도를 유지하는 약재보관용 냉장고에서 보관하였다. 생강, 창출, 강황 및 육계 추출물은 생강, 창출, 강황 및 육계 각각의 총중량에 대하여 10배량에 해당되는 물을 첨가하여 3시간씩 2회 환류냉각 추출하고, 여과지를 이용하여 얻어진 여액을 감압농축기로 용매를 제거함으로써 추출물을 제조하였다.Herbal medicine was purchased from OmniHub, and each sample was stored in a herbal storage refrigerator maintaining a temperature of 5.5 ± 0.3 ℃ and humidity of 55 ± 5%. Ginger, creation, turmeric and broiler extracts were extracted by refluxing twice with reflux for 3 hours by adding water corresponding to 10 times the total weight of each of ginger, creation, turmeric and broilers. The extract was prepared by removing the solvent.
2. 세포실험2. Cell experiment
1) 세포배양1) Cell Culture
HaCaT 세포(사람 각질형성 세포주)는 Dulbecco's Modified Eagle Medium (DMEM, Gibco)에 10% 소태아 혈청(Fetal bovine serum;FBS, Gibco)과 1% 페니실린-스트렙토마이신(penicillin-streptomycin;PS, Gibco)이 함유된 배지에서 37℃, 5% CO2 조건에서 배양하였다.HaCaT cells (human keratinocyte line) were 10% fetal bovine serum (FBS, Gibco) and 1% penicillin-streptomycin (PS, Gibco) in Dulbecco's Modified Eagle Medium (DMEM, Gibco). The medium was incubated at 37 ℃, 5% CO 2 conditions.
2) 세포생존률 분석2) Cell survival rate analysis
HaCaT 세포(사람 각질형성 세포주)에 24시간 동안 각각의 시료를 농도별로 희석하여 처리하고 자외선(UV Crosslinker, Ultra Lum)을 30분간 조사한 후, MTS 어세이(CellTiter Aqueous One Solution Cell proliferation assay kit, 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophynyl)-2H-tetrazolium, inner salt; MTS, Promega Co. Madison, WI, USA) 기법으로 세포 생존능을 490nm에서 마이크로플레이트 리더(Molecular Devices, Sunnyvale, CA, USA) 로 측정하여 시험하였다. Each sample was diluted with HaCaT cells (human keratinocyte cell line) for 24 hours, and irradiated with UV Crosslinker (Ultra Lum) for 30 minutes, followed by MTS assay (CellTiter Aqueous One Solution Cell proliferation assay kit, 3). -(4,5-dimethylthiazol-2-yl) -5- (3-carboxymethoxyphenyl) -2- (4-sulfophynyl) -2H-tetrazolium, inner salt; MTS, Promega Co. Madison, WI, USA) Viability was tested by measuring with a microplate reader (Molecular Devices, Sunnyvale, CA, USA) at 490 nm.
3) MMP-1의 발현량 분석3) Expression level analysis of MMP-1
HaCaT 세포(사람 각질형성 세포주)에 24시간 동안 각각의 시료를 처리하고 자외선(UV Crosslinker, Ultra Lum)을 20mJ/cm2로 조사한 후, MMP-1 ELISA kit (R&D Systems, Inc., Minneapolis, MN, USA)를 이용하여 MMP-1의 발현량을 측정하였다. Each sample was treated with HaCaT cells (human keratinocyte cell line) for 24 hours and irradiated with UV crosslinker (Ultra Lum) at 20 mJ / cm 2 , followed by MMP-1 ELISA kit (R & D Systems, Inc., Minneapolis, MN). , USA) was used to measure the expression level of MMP-1.
상세하게는 96웰 플레이트에 HaCaT 세포를 도말한 후, 본 발명의 생강, 창출, 강황 및 육계 혼합추출물을 다양한 혼합비율별로 처리하였다. 이후, 자외선(UV) 조사하고, 배양물의 상등액을 수집하고 13,000 rpm으로 5분 동안 원심분리하였다. 이후 상등액을 취해 ELISA 키트를 이용한 형광 어세이를 수행하여 MMP-1의 발현량을 정량분석하였다.Specifically, after the HaCaT cells were plated in 96-well plates, ginger, extract, turmeric and broiler mixture extracts of the present invention were treated for various mixing ratios. Thereafter, ultraviolet (UV) irradiation, the supernatant of the culture was collected and centrifuged for 5 minutes at 13,000 rpm. Then, the supernatant was taken and subjected to fluorescence assay using an ELISA kit to quantitatively analyze the expression level of MMP-1.
3. 인체적용시험3. Human application test
1) 시험 목적1) Test purpose
본 시험은 주름이 생성되기 시작하거나 이미 생성된 30~65세의 소음인 여성을 대상으로 12주간 시험제품을 사용하게 하여 주름개선 효과 및 피부 안전성을 평가하기 위함이다(임상시험번호: DEF-HSWIT001(4)-14060).The purpose of this study is to evaluate the effect of wrinkle improvement and skin safety on 12 weeks of use of the test product for women whose wrinkles are starting to occur or who are already aged 30-65 years old. (Clinical Study No .: DEF-HSWIT001 ( 4) -14060).
2) 시험 제품2) test products
- 제품명: KIOM SY(2015SY 1-1)-Product Name: KIOM SY (2015SY 1-1)
- 시험군(A): 생강 추출물(0.09g), 창출 추출물(0.55g), 강황 추출물(0.27g), 육계 추출물(0.09g)의 혼합물 1.0% 함유Test group (A): 1.0% mixture of ginger extract (0.09g), extract extract (0.55g), turmeric extract (0.27g), broiler extract (0.09g)
- 대조군(B): 생강 추출물, 창출 추출물, 강황 추출물, 육계 추출물 미함유-Control group (B): Ginger extract, creation extract, turmeric extract, broiler extract free
- 제품의 성상: 크림-Appearance of product: Cream
- 제품의 보관: 실온 보관-Storage of the product: Store at room temperature
- 제품의 유효 성분: 생강 추출물(0.09g), 창출 추출물(0.55g), 강황 추출물(0.27g), 육계 추출물(0.09g)의 혼합물 1.0%-Active ingredient of the product: 1.0% mixture of ginger extract (0.09g), extract extract (0.55g), turmeric extract (0.27g), broiler extract (0.09g)
- 제품의 사용 방법: 12주 동안 1일 2회 세안 후 스킨 다음 단계에서 제품 A와 B를 안면 좌, 우측 정해진 눈가 부위에 바르고 흡수시키게 하였다. 피험자는 이중맹검법과 무작위 배정에 따라 두 그룹으로 나누어 A그룹은 좌측에 시험군(제품 A), 우측에 대조군(제품 B)을 사용하게 하고, B그룹은 좌측에 대조군(제품 B), 우측에 시험군(제품 A)을 사용하게 하였다.-How to use: After washing twice a day for 12 weeks, skin A and B were applied to the left and right eye areas and absorbed after the next step. Subjects were divided into two groups according to the double-blind method and randomization. Group A had the test group (product A) on the left side and control group (product B) on the right side, and group B had the control group (product B) on the left side and the right side. A test group (product A) was used.
3) 시험 방법3) test method
모든 피험자는 방문 시마다 시험부위를 세척한 다음에 항온항습실(22±2℃, 50±5%)에 입실하였으며, 30분 동안 안정을 취한 후 시험에 참여하였다.All subjects were cleaned at each visit, and then placed in a constant temperature and humidity room (22 ± 2 ° C, 50 ± 5%) and rested for 30 minutes before participating in the test.
평가는 제품 사용 전(0주)과 사용 후 각 시점(4주, 8주, 12주)에서 육안평가, 피부 주름 파라미터 측정, 피험자에 의한 설문평가 및 시험자의 관찰과 문진을 통해 피부 안전성을 평가하였다.The evaluation is performed on the skin safety through visual evaluation, skin wrinkle parameter measurement, questionnaire evaluation by the subject and observation and questionnaire at each time before and after use of the product (week 0 and week 4, 8, 12). It was.
① 피험자 선정① Subject Selection
피부 임상 시험 전 SCAT 프로그램(한국공개특허 제2012-0034475호, JH DO. et.al 2012, Development of an intefrated Sasang constitution diagnoisis method using face, body shape, voice, and questionnaire information 12:85)을 이용한 체질 판별이 된 임상 대상자 선정 절차에 따라 선별하였다. Constitution using the SCAT program (Korea Patent Publication No. 2012-0034475, JH DO. Et.al 2012, Development of an intefrated Sasang constitution diagnoisis method using face, body shape, voice, and questionnaire information 12:85) Screening was performed according to the identified clinical subject selection procedure.
본 시험은 30~65세의 소음인 여성을 모집하였으며, 모집결과, 피험자 선정 기준에 부합하고 제외 기준에 부합하지 않는 소음인 여성 피험자 22명이 모집되었으며, 이들의 연령은 35~54세(평균연령: 45.2±5.2세)로 분포하였다.The study recruited noisy women between the ages of 30 and 65 and recruited 22 noisy female subjects who met the subject selection criteria and did not meet the exclusion criteria. Their age ranged from 35 to 54 years (mean age: 45.2). ± 5.2 years old).
피부 주름은 더마프로 피부과학연구소의 SOP(standard operating procedure)에 따라 주름이 생성되기 시작하거나 이미 생성된 피험자를 대상으로 시험의 목적과 방법, 기대 효능과 이상반응을 설명하여 참여 의사를 보이는 자는 시험 참가 동의서를 작성하고 시험에 참여하도록 하였다.Skin wrinkles are tested by dermapro dermatological research institutes who have started to produce wrinkles or who have already participated in this study. A participation agreement was written and the participants participated in the test.
또한, 소음인 인자 판별을 위해 시험 시작 전, 체질량 지수(BMI) 측정(Inbody 330, Biospace, Korea), 신체 둘레 측정, 사진촬영 및 사상체질 진단 설문평가를 진행하였고, 한국한의학연구원의 사상체질 진단 프로그램(SCAT, Sasang Constitutional Analysis Tool)을 이용하여 소음인을 선정하였다.In addition, before the test, BMI measurement (Inbody 330, Biospace, Korea), body circumference measurement, photography and Sasang Constitution Diagnosis Questionnaire Evaluation were conducted to determine the noise factor. The noise factor was selected using (SCAT, Sasang Constitutional Analysis Tool).
- 체질을 대략 분류할 수 있는 설문문항 2-3개를 이용하여 임상 대상자 1차 필터링 시행하였다. -The primary filtering of the clinical subjects was carried out using 2-3 questions that can roughly classify the constitution.
- 1차 필터링된 피험자를 대상으로 SCAT를 통하여 체질을 진단하였으며, 본 발명에 따르는 소음인 체질인 자를 선정하였다. -The constitution was diagnosed through SCAT in the first filtered subjects, and the constitution factor, which is the noise according to the present invention, was selected.
- 피부 임상 기준 인원인 20명을 초과한 22명을 최종 임상 시험 피험자로 선정하였다.-22 patients who exceeded the skin clinical baseline of 20 were selected as the final clinical trial subjects.
선정 과정에서 피험자마다 계산된 태음(TE), 소음(SE), 소양(SY) 체질 값 중 가장 높은 체질값(max(TE,SE,SY))과 두 번째로 높은 체질값(median(TE,SE,SY))의 차이가 큰 순서대로 정렬해서 소음인으로 판단된 22명(중도탈락 1명 포함)을 선정하였다. The highest constitution value (max (TE, SE, SY)) and second highest constitution value (median (TE) SE, SY)) were selected in order of big difference, and 22 people (including one dropout) who were judged as noise noise were selected.
[피험자 선정기준][Subject selection criteria]
하기에 기재한 바와 같은 조건에 부합되는 지원자를 시험 대상군으로 선정하였다. Candidates who met the conditions as described below were selected as test subjects.
- 30~65세의 소음인(SCAT 프로그램으로 체질진단)으로 주 시험자의 판단에 따라 시험부위에 주름이 있는 자 -A person who has wrinkles on the test site according to the judgment of the main investigator by the noise person (diagnosis by SCAT program) of 30 ~ 65 years old
- 피부질환을 포함하는 급, 만성 신체 질환이 없는 건강한 자-Healthy person without grade and chronic physical disease including skin disease
- 시험에 앞서 시험의 목적, 내용 등에 대해 충분히 설명을 듣고 자발적으로 서면 동의서에 서명한 지원자-Applicants who have fully explained the purpose and content of the examination prior to the examination and voluntarily signed the written consent.
- 시험기간 동안 추적 관찰이 가능한 자-Those who can follow up during the test
[피험자 제외기준][Subject exclusion criteria]
하기에 기재된 항목에 해당되는 지원자는 시험 대상군에서 제외하였다.Applicants corresponding to the items listed below were excluded from the test group.
- 임신, 수유 중 또는 6개월 이내에 임신을 계획하고 있는 경우-If you are planning to become pregnant, during lactation or within 6 months
- 피부질환의 치료를 위해 스테로이드가 함유된 피부 외형제를 1개월 이상 사용한 경우-If the skin steroid containing steroids is used for more than 1 month to treat skin disease
- 동일한 시험에 참가한 뒤 6개월이 경과되지 않은 경우-6 months have passed since participating in the same exam
- 민감성, 과민성 피부를 가진 경우-If you have sensitive or sensitive skin
- 시험부위에 점, 여드름, 홍반, 모세혈관 확장 등의 피부 이상 소견이 있는 경우-If there are any abnormalities on the test site such as spots, acne, erythema, and capillary dilatation
- 시험시작 3개월 이내에 시험부위에 동일 또는 유사한 화장품 또는 의약품을 사용한 경우-When the same or similar cosmetics or medicines are used at the test site within 3 months of starting the test
- 시험부위에 시술(박피술, 보톡스, 기타 피부관리 등)을 받거나 6개월 이내 계획한 경우-If you have undergone a procedure (dermabrasion, botox, other skin care, etc.) at the test site or plan within 6 months
- 만성 소모성 질환이 있는 경우 (천식, 당뇨, 고혈압 등)-Have chronic wasting diseases (asthma, diabetes, high blood pressure, etc.)
- 그 외 주 시험자의 판단으로 시험이 곤란하다고 판단되는 경우-If it is judged difficult by other principal investigator's judgment
[피험자 제한사항] [Subject Restrictions]
피험자는 시험제품 이외의 기능성 화장품 혹은 의약품과의 혼용을 금하도록 하였고, 시험제품 외에 사용하는 기초 화장품은 기능성 성분이 없는 스킨, 로션만을, 메이크업 화장품은 베이스 메이크업(파운데이션, 파우더), 펜슬, 립스틱만을 사용하도록 하였으며, 선 크림 제품은 외출 시 반드시 사용하도록 하였다. 그리고 방문(측정)시에는 색조 화장은 하지 않고 방문하도록 하였다.Subjects should not mix with functional cosmetics or medicines other than the test product.The basic cosmetics used outside the test product are only skins and lotions without functional ingredients. Sun cream products should be used when going out. At the time of visit (measurement), the visit was made without color makeup.
[피험자 수 및 이에 대한 근거][Number of subjects and the rationale for this]
피험자 수는 기능성 화장품의 유효성 평가를 위한 가이드라인(2003, 2005), 화장품 표시, 광고 실증을 위한 시험방법 가이드라인(2013)에 준하여 20명 이상을 선정하여 시험을 시행하였다.The number of subjects was tested by selecting 20 or more subjects according to guidelines for evaluating the effectiveness of functional cosmetics (2003, 2005), and guidelines for test methods for cosmetic labeling and advertisement (2013).
② 피부 주름의 육안 평가② Visual evaluation of skin wrinkles
육안 평가는 양측 눈가의 주름 상태에 대해 주름평가 기준에 의거 2인의 시험자가 일정한 조명하에 독립적으로 평가하였다. 각 평가 시점마다 주름 상태의 등급을 10단계(0.5점 단위)로 기록하고, 시험자 2인의 평균값을 분석하였다(표 1).Visual evaluation was independently performed by two test subjects under certain illumination according to the wrinkle evaluation criteria for wrinkles of both eyes. For each evaluation time point, the grade of wrinkles was recorded in 10 steps (0.5 point units), and the average value of two testers was analyzed (Table 1).
다니엘의 판별기준을 변형한 육안 주름평가 기준Visual wrinkle criterion modified from Daniel's criteria
점수score 주름평가 기준 Wrinkle Evaluation Criteria
00 피부에 주름이 없으며 피부 결이 섬세하다. There are no wrinkles on the skin and the skin texture is delicate.
1One 피부에 얕은 주름이 보이기 시작한다. Shallow wrinkles begin to appear on the skin.
22 피부에 얕은 주름이 보인다. Shallow wrinkles appear on the skin.
33 얕은 주름이 많거나 보통 주름이 보이기 시작한다. Many wrinkles or normal wrinkles begin to appear.
44 피부에 보통 주름이 보인다. Usually wrinkles appear on the skin.
55 보통주름이 있으나 깊은 주름은 보이지 않는다. It has normal wrinkles but no deep wrinkles.
66 보통 주름이 많거나 깊은 주름이 보이기 시작한다. Usually wrinkles or deep wrinkles begin to appear.
77 피부에 깊은 주름이 보인다. Deep wrinkles appear on the skin.
88 피부에 깊은 주름이 많다. There are many deep wrinkles on the skin.
99 피부에 깊은 주름이 매우 많다.There are many deep wrinkles on the skin.
③ 레플리카를 이용한 피부 주름 파라미터 평가③ Evaluation of skin wrinkle parameter using replica
피부 주름은 각 평가시점에서 Visioline® VL650 (C+K, Germany)을 이용하여 피부 레플리카 이미지를 분석하여 평가하였다. 이 장치는 빛을 레플리카에 조사하였을 때 피부 형태에 따른 레플리카의 두께에 따라 투과된 빛의 명암이 달라지는 것을 이용하여 이를 수치화하여 주름의 임의적 단위인 R1, R2, R3, R4, R5를 측정하였다. Skin wrinkles were evaluated by analyzing skin replica images using Visioline® VL650 (C + K, Germany) at each time point. When the device is irradiated with light, the intensity of transmitted light varies depending on the thickness of the replica according to the shape of the skin.
R1은 주름 프로필(profile) 중 가장 높은 꼭대기 값과 가장 낮은 계곡의 값의 차이를 의미하며, R2는 주름 프로필(profile)을 5개로 균등하여 5개의 R1 값을 구하여 이 중 가장 큰 값을 의미한다. R3는 주름 프로필을 5개씩 균등하여 연속적 5개의 R1 값을 산술 평균한 값으로서, R1과 R2에 비해 artifacts가 제거된 값이 된다. R1, R2, R3는 주름의 깊이를 나타내는 값으로 이해할 수 있다. R4는 프로필(profile)중 가장 꼭대기 값에서 수평선을 그어 프로필과 이루는 면적을 적분하여 프로필의 중간선의 길이로 나눈 값으로서 피부 주름의 평균 깊이를 의미한다. R5는 프로필의 중간선과 프로필이 이루는 면적을 적분하여 프로필의 중간선의 길이로 나눈 값으로서 피부의 평균 거칠기를 나타낸다(도 3). R1 is the difference between the highest peak and the lowest valley of the wrinkle profile, and R2 equals five wrinkle profiles to get five R1 values, which is the largest of them. . R3 is an arithmetic mean of five consecutive R1 values by equalizing five wrinkle profiles, resulting in the removal of artifacts compared to R1 and R2. R1, R2, and R3 can be understood as values representing the depth of wrinkles. R4 is the average depth of skin wrinkles by drawing the horizontal line at the top of the profile and integrating the area with the profile divided by the length of the midline of the profile. R5 is the mean roughness of the skin divided by the length of the midline of the profile by integrating the area between the midline of the profile and the profile (FIG. 3).
이러한 원리로 R1, R2, R3, R4, R5를 측정함에 있어서 가로(horizontal), 세로(vertical), 원형(circle)의 세 가지 방식이 있는데 피부의 결과 주름은 여러 방향으로 생기기 때문에 이러한 특성을 고려하여 원형(circle) 방식으로 측정하였다.Based on this principle, there are three methods for measuring R1, R2, R3, R4, and R5: horizontal, vertical, and circular. Was measured in a circular manner.
④ 사진 촬영④ Take a picture
각 평가 시점에서 안면 피부 촬영장치(VISIA® CR, Canfield, USA)를 이용하여 안면 좌, 우 측면을 촬영하였다.At each evaluation point, facial left and right sides were photographed using a facial skin imaging device (VISIA® CR, Canfield, USA).
⑤ 피험자에 의한 설문평가⑤ Survey evaluation by subject
제품의 효능에 관한 설문은 제품 사용 4주, 8주, 12주 후 평가시점에서 피험자로 하여금 5점 척도(1, 전혀 그렇지 않다; 2, 그렇지 않은 편이다; 3. 차이가 없다; 4. 그런 편이다; 5. 매우 그렇다)로 설문을 작성하도록 하였다. 또한, 제품 사용성에 관한 설문은 제품 사용 12주 후 평가시점에서 5단계 척도(1, 전혀 좋지 않다; 2, 좋지 않은 편이다; 3, 보통이다; 4, 좋은 편이다; 5, 매우 좋다)로 실시하여, 피험자들이 작성한 긍정적인 답변(4, 좋은 편이다; 5, 매우 좋다)을 분석하였다.The questionnaire about the efficacy of the product was conducted by the subject at the 4, 8, and 12 weeks of product use.The subjects were assessed at the 5-point scale (1, not at all; 2, not at all; 3. no difference; 5. Very much). In addition, the questionnaire on product usability was assessed on a five-level scale (1, not at all; 2, not good; 3, moderate; 4, good; 5, very good) at the time of evaluation 12 weeks after product use. The positive responses (4, good; 5, very good) written by the subjects were analyzed.
⑥ 피부 안전성 평가⑥ Skin safety assessment
제품 사용 4주, 8주, 12주 후 시점에서 문진과 시험자의 관찰을 통해 주관적 피부 자극감과 객관적 피부 자극을 평가하였다.Subjective skin irritation and objective skin irritation were assessed through questionnaires and observations at 4, 8 and 12 weeks after product use.
4) 통계분석4) Statistical Analysis
모든 데이터는 SPSS 패키지 프로그램(IBM, USA)을 이용하여 통계적 유의성을 검증하였으며, 육안평가의 경우 시험자 간 신뢰도 분석으로 ICC(Intraclass correlation coefficient) 분석을 수행하고, ICC 값이 0.8 이상이면 시험자 간의 신뢰도를 인정하여 시험자의 평균값을 적용하여 분석하였다. 또한, 정규성은 첨도 (kurtosis)와 왜도(skewness)를, 사전 동질성은 paired t-테스트를 통해 검증하였다. All data were verified statistical significance using SPSS package program (IBM, USA) .In case of visual evaluation, intraclass correlation coefficient (ICC) analysis was performed by inter-tester reliability analysis. It was analyzed by applying the average value of the investigator. In addition, normality was verified by kurtosis and skewness, and prior homogeneity was verified by paired t-test.
동일 피험자에게서 반복 측정한 데이터에 존재하는 상호의존성(교호작용), 군간 비교 및 시점별 전 후 변화를 확인하기 위해 반복측정 분산분석법(Repeated Measures ANOVA)을 적용하였다. 각 시점별 군간 비교 및 시점별 전후 변화는 제품 사용 전의 값이 동질하다는 조건 하에서 Mann-Whitney U-테스트를 이용하였고, 제품 사용성 설문평가는 카이-스퀘어 테스트(Chi-Square test)를 이용하여 분석하였다. 각 통계학적 유의수준은 p 값이 0.05 미만인 것을 유의한 것으로 하였다.Repeated Measures ANOVA was applied to identify interdependence (interaction), cross-group comparison, and before and after changes in time-point data in the same subject. The comparison between groups at each time point and the change before and after each time point were performed using the Mann-Whitney U-test under the condition that the values before and after the use of the product were used. The product usability questionnaire was analyzed using the Chi-Square test. . Each statistical significance level was considered to be significant that the p value is less than 0.05.
실시예Example 1. 생강, 창출,  Ginger, creation, 강황curcuma 및 육계 추출물의 혼합물 제조 And a mixture of broiler extracts
상기 [재료 및 방법]에 기재한 바와 같이 생강, 창출, 강황 및 육계 추출물을 제조하여, 생강:창출:강황:육계의 중량비가 1:1:1:1, 1:2:2:1, 1:3:3:1, 1:3:6:1, 1:6:3:1이 되도록 혼합하여 혼합 추출물을 각각 제조하였다. As described in [Materials and Methods], ginger, creation, turmeric and broiler extracts were prepared, and the weight ratio of ginger: creation: turmeric: chicken was 1: 1: 1: 1, 1: 2: 2: 1,1 The mixed extracts were prepared by mixing 1: 3: 3: 1, 1: 3: 6: 1, 1: 6: 3: 1.
이후 실시예에서는 본 실시예 1에서 제조한 혼합추출물을 이용하여 세포 생존률 및 MMP-1 발현량을 분석하였으며, 효과가 가장 우수한 혼합 추출물을 선정하여 소음인 21명을 대상으로 주름 개선효과를 분석하였다. In the following examples, the cell viability and MMP-1 expression levels were analyzed using the mixed extract prepared in Example 1, and the most effective mixed extract was selected to analyze the wrinkle improvement effect on 21 people with noise.
실시예Example 2. 생강, 창출,  2. ginger, creation, 강황curcuma 및 육계 혼합 추출물에 대한 세포  And cell for broiler mixed extract 생존률Survival rate 분석 analysis
상기 실시예 1에서 제조한 1:1:1:1, 1:2:2:1, 1:3:3:1, 1:3:6:1 및 1:6:3:1의 중량비가 되도록 혼합한 생강, 창출, 강황 및 육계 혼합 추출물을 각각 HaCaT 세포(사람 각질형성 세포주)에 24시간 동안 처리하고, 자외선(UV Crosslinker, Ultra Lum)을 30분간 조사한 후, MTS 어세이를 수행한 결과, 도 1에 개시한 바와 같이, 생강, 창출, 강황 및 육계 혼합 추출물의 혼합비에 따라 세포 생존률이 다르게 나타났으며, 자외선 조사에 의해 세포 생존률이 51.09%로 감소하였고, 혼합비가 1:6:3:1인 생강, 창출, 강황 및 육계 혼합 추출물 50㎍/㎖을 처리한 경우, 세포 생존률이 74.85%이고, 100㎍/㎖을 처리한 경우, 세포 생존률이 80.99%로 나타났으며, 혼합비가 1:3:6:1인 생강, 창출, 강황 및 육계 혼합 추출물 50㎍/㎖을 처리한 경우, 세포 생존률이 93.93%이고, 100㎍/㎖을 처리한 경우, 세포 생존률이 94.11%로 나타났다.The weight ratio of 1: 1: 1: 1, 1: 2: 2: 1, 1: 3: 3: 1, 1: 3: 6: 1 and 1: 6: 3: 1 prepared in Example 1 The mixed ginger, extract, turmeric, and broiler mixed extracts were treated with HaCaT cells (human keratinocyte line) for 24 hours, irradiated with ultraviolet (UV Crosslinker, Ultra Lum) for 30 minutes, and then subjected to MTS assay. As shown in Figure 1, the cell survival rate was different according to the mixing ratio of the ginger, the production, turmeric and broiler mixture extract, the cell survival was reduced to 51.09% by UV irradiation, the mixing ratio 1: 6: 3: The cell survival rate was 74.85% when treated with 50 μg / ml of ginger, production, turmeric and broiler mixed extract of 1, and the cell survival rate was 80.99% when treated with 100 μg / ml. The cell survival rate was 93.93% when treated with ginger, production, turmeric and broiler extracts 3: 3: 1, and the cell viability was 94.11 when treated with 100 μg / ml. Appeared in%.
한편, 생강, 창출, 강황 및 육계 추출물을 각각 단독으로 처리한 경우, 세포 생존률이 오히려 UV 조사만 했을 경우보다도 낮거나 거의 유사한 정도의 세포생존률을 나타냈다. On the other hand, when the ginger, the production, turmeric and broiler extracts were treated alone, the cell survival rate was lower or almost similar to that of the UV irradiation alone.
실시예 3. 생강, 창출, 강황 및 육계 혼합 추출물의 MMP -1의 발현량에 대한 효과 Example 3 Effect of Ginger, Produced, Turmeric and Broiler Mixture Extracts on Expression of MMP- 1
콜라겐 분해 효소(MMPs; matrix metalloproteinases)는 세포외기질(extracellular matrix)과 기저막(basement membrane)의 분해에 관여함으로써, 콜라겐 감소에 영향을 미치는 효소이다. Collagen degrading enzymes (MMPs) are enzymes that affect collagen reduction by being involved in the degradation of extracellular matrix and basement membrane.
본 실시예 3에서는 콜라겐 감소에 중요한 영향을 미치는 콜라겐 분해 효소(MMPs; matrix metalloproteinases)의 발현량의 변화를 분석함으로써, 본 발명의 유효성분인 생강, 창출, 강황 및 육계 추출물의 혼합물의 주름개선 효과가 있는지 여부를 확인하였다. In Example 3, the effect of improving wrinkles of a mixture of ginger, creation, turmeric and broiler extracts, which are active ingredients of the present invention, was analyzed by analyzing the change in the expression level of collagen degrading enzymes (MMPs; matrix metalloproteinases), which have a significant effect on collagen reduction Check whether there is.
도 2에 개시한 바와 같이, 자외선을 조사하지 않은 세포에서는 MMP-1의 발현량이 매우 낮았으나, 자외선 조사에 의해 MMP-1의 발현이 현저하게 증가하였다는 것을 확인할 수 있었고, 본 발명의 생강, 창출, 강황 및 육계 추출물을 비율별로 혼합하여 처리한 경우, 자외선 조사한 경우에 비교하여 MMP-1의 발현량(ng/㎖)이 현저하게 감소하였다. 특히, 생강, 창출, 강황 및 육계 추출물을 1:6:3:1의 중량비로 혼합한 경우, MMP-1의 발현량이 매우 낮다는 것을 확인함으로써, 본 발명의 유효성분이 주름개선에 효과가 있다고 판단하였다. As shown in FIG. 2, although the expression level of MMP-1 was very low in the cells not irradiated with ultraviolet rays, it was confirmed that the expression of MMP-1 was significantly increased by ultraviolet irradiation. In the case of treatment with the ratio of the production, turmeric and broiler extracts, the expression level (ng / ml) of MMP-1 was significantly reduced compared to the case of ultraviolet irradiation. In particular, when ginger, extract, turmeric and broiler extracts are mixed at a weight ratio of 1: 6: 3: 1, by confirming that the expression level of MMP-1 is very low, it is determined that the active ingredient of the present invention is effective in improving wrinkles. It was.
실시예 4. 1:6:3:1의 중량비로 혼합한 생강, 창출, 강황 및 육계 혼합 추출물을 포함하는 시험제품을 이용한 임상 시험 Example 4 Clinical Trials Using Test Products Containing Ginger, Produce, Turmeric, and Broiler Mixture Extracts Mixed in a Weight Ratio of 1: 6: 3: 1
본 실시예 4에서는 상기 실시예 2 및 3의 결과를 바탕으로, 가장 효과가 우수한 1:6:3:1의 중량비로 혼합한 생강, 창출, 강황 및 육계 혼합 추출물을 포함하는 시험제품을 제조하고, 이를 21명의 소음인에게 적용하는 임상시험을 실시하였다. In Example 4, based on the results of Examples 2 and 3, to prepare a test product containing a mixture of ginger, creation, turmeric and broiler mixed extract in a weight ratio of 1: 6: 3: 1, the most effective We conducted a clinical trial that applied it to 21 noisy patients.
본 시험은 제외기준 및 선정기준에 준하는 30~65세의 여성 피험자 총 22명이 참여하였으나 1명(#8; 개인사정)이 탈락하여 총 21명(평균 45.2±5.2세)의 피험자가 시험 종료 시까지 전 과정을 성실히 수행하였다. 피험자의 피부 특성은 설문에 의해 조사하였다.In this test, 22 female subjects aged 30 to 65 who met the exclusion criteria and selection criteria participated, but one (# 8; individual) drop out and 21 subjects (mean 45.2 ± 5.2 years old) were completed. The whole process was faithfully carried out. The skin characteristics of the subjects were examined by questionnaire.
21명 중에서 그룹 A는 본 발명의 유효성분인 1:6:3:1의 생강, 창출, 강황 및 육계 혼합 추출물을 함유하는 시험군이고, 그룹 B는 대조군으로 본 발명의 유효성분을 함유하지 않은 제품을 사용한 그룹이다. 하기 표 2 내지 4에 임상 시험에 참여한 시험군(A)와 대조군(B)의 정보, 피부타입 및 피부 상태를 개시하였다.Group 21 is a test group containing ginger, extract, turmeric and broiler mixed extract of 1: 6: 3: 1, which is an active ingredient of the present invention, and group B is a control group that does not contain the active ingredient of the present invention. The group that used the product. Tables 2 to 4 below disclose information, skin types and skin conditions of test groups (A) and control groups (B) participating in clinical trials.
시험군(A) 및 대조군(B)의 정보 (N=22명)Information from test group (A) and control group (B) (N = 22)
NONO 성명name 나이age 사상체질별 분류Classification by Sasang Constitution 그룹group 중도 탈락Dropout
1One L*JL * J 4848 소음인Noisemaker AA
22 O*SO * S 4848 소음인Noisemaker BB
33 A*JA * J 4747 소음인Noisemaker BB
44 I*EI * E 3939 소음인Noisemaker AA
55 L*YL * Y 4848 소음인Noisemaker AA
66 H*SH * S 4141 소음인Noisemaker AA
77 K*JK * J 5050 소음인Noisemaker BB
88 J*JJ * J 5757 소음인Noisemaker BB 개인사정personal issues
99 K*SK * S 5454 소음인Noisemaker AA
1010 L*SL * S 4545 소음인Noisemaker BB
1111 Y*SY * S 5050 소음인Noisemaker AA
1212 P*SP * S 3838 소음인Noisemaker BB
1313 K*JK * J 3636 소음인Noisemaker AA
1414 K*SK * S 4545 소음인Noisemaker BB
1515 Y*YY * Y 3535 소음인Noisemaker BB
1616 K*HK * H 4747 소음인Noisemaker AA
1717 K*JK * J 4545 소음인Noisemaker AA
1818 J*SJ * S 5353 소음인Noisemaker BB
1919 J*SJ * S 4141 소음인Noisemaker BB
2020 L*HL * H 4646 소음인Noisemaker AA
2121 K*SK * S 4949 소음인Noisemaker AA
2222 J*HJ * H 4545 소음인Noisemaker AA
평균나이±표준편차: 45.2±5.2세(탈락 피험자 제외)Mean age ± standard deviation: 45.2 ± 5.2 years (excluding dropout subjects)
시험군 및 대조군의 피부타입 (N=21)Skin type of test and control group (N = 21)
항목Item 분류Classification 시험자 수(N)Number of testers (N) 비율(%)ratio(%)
연 령(Age)Age 30대30 spaces 44 19.0519.05
40대40 spaces 1313 61.9061.90
50대50 spaces 44 19.0519.05
피부타입(Skin type)Skin type 건성inattention 1010 47.6247.62
중성 neutrality 66 28.5728.57
지성 Intelligence 22 9.529.52
건지성 Guernsey 33 14.2914.29
문제성 피부 Problem skin 00 0.000.00
시험군 및 대조군의 피부 상태 (N=21)Skin condition of test and control groups (N = 21)
항목Item 분류Classification 시험자 수 (N)Number of testers (N) 비율(%)ratio(%)
수분(Hydration) Hydration 촉촉Moist 00 0.000.00
보통usually 1111 52.3852.38
부족lack 1010 47.6247.62
유분(Sebum)Oil 번들거림Bundle 1One 4.764.76
보통usually 1111 52.3852.38
부족lack 99 42.8642.86
표면 상태(Surface)Surface 부드러움Soft 55 23.8123.81
보통usually 1313 61.9061.90
거침 coarseness 33 1.291.29
두께(Thickness)Thickness 얇은 편Thin 88 38.1038.10
보통usually 1212 57.1457.14
두꺼운 편Thick 1One 4.764.76
자외선 노출시간(Duration of UV exposure)Duration of UV exposure 1시간 이내in 1 hour 66 28.5728.57
1~3시간1-3 hours 1010 47.6247.62
3시간 이상More than 3 hours 55 23.8123.81
수면시간(Sleeping hours)Sleeping hours 5시간 이하5 hours or less 1One 4.764.76
5~8시간5-8 hours 1818 85.7185.71
8시간 이상More than 8 hours 22 9.529.52
흡연 유무(Smoking)Smoking 피우지 않음.Do not smoke. 2121 100.00100.00
10개피 이내Within 10 pieces 00 0.000.00
10개피 이상More than 10 00 0.000.00
자극 감수성(Irritability)Irritability Yes 33 14.2914.29
아니오no 1818 85.7185.71
따가움 감수성(Stinging)Stinging Yes 22 9.529.52
아니오no 1919 90.4890.48
이상반응 경험(Adverse reaction)Adverse reaction Yes 00 0.000.00
아니오no 2121 100.00100.00
1) 피부 주름의 육안평가 분석1) Visual evaluation of skin wrinkles
본 실시예에서는 상기한 바와 같이 제품을 적용 전과 적용 4주 후, 8주 후, 12주 후에 시험군과 대조군의 피부를 육안평가 값을 RM ANOVA를 이용하여 분석하였다.In the present embodiment, as described above, the skin of the test group and the control group was visually analyzed using RM ANOVA before, after 4 weeks, after 8 weeks, and after 12 weeks of application.
그 결과, 육안 평가에서는 시험군과 대조군 사이에 유의한 차이가 나타나지는 않았다(표 5).As a result, the visual evaluation did not show a significant difference between the test group and the control group (Table 5).
생강, 창출, 강황 및 육계 혼합 추출물을 포함하는 크림 타입의 제품을 사용한 시험군(A)과 대조군(B)의 육안 평가에 대하여 통계학적 의미(p 값) Statistical significance (p value) for visual evaluation of test group (A) and control group (B) using a cream-type product containing ginger, crude, turmeric and broiler mixed extracts
그룹비교(N=21) Group comparison (N = 21) 4주4 Weeks 8주8 Weeks 12주12 Weeks
시험군 vs. 대조군Test group vs. Control -- -- 0.3290.329
2) 레플리카를 이용한 피부 주름 파라미터 분석2) Skin wrinkle parameter analysis using replica
R1와 R4 파라미터가 제품 사용 12주 후 시점에서 시험군이 대조군에 비해 유의하게 개선되었음을 확인하였다(표 6, 도 4 및 도 5).The R1 and R4 parameters were found to be significantly improved in the test group compared to the control group at 12 weeks after product use (Table 6, Figures 4 and 5).
생강, 창출, 강황 및 육계 혼합 추출물을 포함하는 크림 타입의 제품을 사용한 시험군(A)과 대조군(B)의 레플리카 분석에 대하여 통계학적 의미(p 값) Statistical significance (p value) for replica analysis of test group (A) and control group (B) using a cream type product containing ginger, crude, turmeric and broiler mixed extracts
파라미터parameter 그룹group 4주4 Weeks 8주8 Weeks 12주12 Weeks
R1R1 시험군 vs. 대조군Test group vs. Control 0.2620.262 0.2590.259 0.000*0.000 *
R2R2 시험군 vs. 대조군Test group vs. Control 0.2750.275 0.0850.085 0.2150.215
R3R3 시험군 vs. 대조군Test group vs. Control 0.4100.410 0.6230.623 0.1490.149
R4R4 시험군 vs. 대조군Test group vs. Control 0.1040.104 0.1100.110 0.024*0.024 *
R5R5 시험군 vs. 대조군Test group vs. Control 0.1480.148 0.0770.077 0.0520.052
*: p값이 0.05 미만인 경우이고, 시험군과 대조군 사이에 유의하게 차이가 있다는 것을 의미한다.*: p value is less than 0.05, which means that there is a significant difference between the test group and the control group.
3) 피부 안전성 평가3) Skin safety assessment
본 시험기간 동안 모든 피험자에게서 피부 이상반응은 관찰되지 않았다. 따라서 본 발명의 유효성분은 독성 또는 부작용이 없는 것으로 판단하였다(표 7).No skin adverse events were observed in all subjects during this study. Therefore, the active ingredient of the present invention was determined to have no toxicity or side effects (Table 7).
생강, 창출, 강황 및 육계 혼합 추출물을 포함하는 크림 타입의 제품을 사용한 시험군(A)과 대조군(B)의 피부 이상반응에 대한 피부 안전성 평가 결과 Evaluation of Skin Safety on Skin Adverse Events in Test Group (A) and Control Group (B) Using Cream-Type Products Containing Ginger, Produce, Turmeric and Broiler Mixture Extracts
증상 (Symptom)Symptom 4주4 Weeks 8주8 Weeks 12주12 Weeks
AA BB AA BB AA BB
주관적자극감(Subjective irritation) Subjective irritation 가렵다 (Itching)Itching 00 00 00 00 00 00
바늘로 찌르듯이 아프다(Prickling)Sick like a needle stab (Prickling) 00 00 00 00 00 00
근질거린다 (Tickling) Tickling 00 00 00 00 00 00
화끈거린다 (Burning)Burning (Burning) 00 00 00 00 00 00
따끔거린다 (Stinging)Stinging 00 00 00 00 00 00
뻣뻣하다 (Stiffness) Stiffness 00 00 00 00 00 00
당긴다 (Tightening) Tightening 00 00 00 00 00 00
기타 (etc.) Miscellaneous 00 00 00 00 00 00
객관적자극(ObjectiveIrritation) Objective Irritation 홍반 (Erythema)Erythema 00 00 00 00 00 00
부종 (Edema) Edema 00 00 00 00 00 00
인설 (Scale) Scale 00 00 00 00 00 00
구진 (Papule) Papule 00 00 00 00 00 00
기타 (etc.) Miscellaneous 00 00 00 00 00 00
총 이상반응자 수(Total number of subjects)Total number of subjects 00 00 00 00 00 00

Claims (10)

  1. 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 화장료 조성물.A cosmetic composition for improving skin wrinkles and anti-aging, comprising ginger, extract, turmeric and broiler mixed extract as active ingredients.
  2. 제1항에 있어서, 상기 생강, 창출, 강황 및 육계 혼합 추출물은 물, C1~C4의 저급알코올, 프로필렌글리콜, 에틸아세트산, 부틸렌글리콜, 글리세린, 에테르 및 클로로포름 중에서 선택된 하나 이상의 용매를 이용하여 추출한 것을 특징으로 하는 피부 주름 개선 및 항노화용 화장료 조성물.The method of claim 1, wherein the ginger, extract, turmeric and broiler mixed extract using at least one solvent selected from water, C 1 ~ C 4 lower alcohol, propylene glycol, ethyl acetate, butylene glycol, glycerin, ether and chloroform Skin wrinkle improvement and anti-aging cosmetic composition, characterized in that extracted by.
  3. 제1항에 있어서, 상기 생강, 창출, 강황 및 육계 추출물의 혼합비는 1:2.5~6.5:2.5~6.5:1 중량비인 것을 특징으로 하는 피부 주름 개선 및 항노화용 화장료 조성물.According to claim 1, wherein the blending ratio of the ginger, creation, turmeric and broiler extract is 1: 2.5 to 6.5: 2.5 to 6.5: 1 weight ratio characterized in that the cosmetic composition for skin wrinkle improvement and anti-aging.
  4. 제1항에 있어서, 상기 화장료 조성물은 사상체질 중에서 소음인용인 것을 특징으로 하는 피부 주름 개선 및 항노화용 화장료 조성물.The cosmetic composition for improving skin wrinkles and anti-aging according to claim 1, wherein the cosmetic composition is used for noise in the filamentous constitution.
  5. 제1항에 있어서, 상기 화장료 조성물은 MMP-1의 발현을 저해하는 것을 특징으로 하는 피부 주름 개선 및 항노화용 화장료 조성물.The cosmetic composition for improving skin wrinkles and anti-aging according to claim 1, wherein the cosmetic composition inhibits the expression of MMP-1.
  6. 제1항에 있어서, 상기 화장료 조성물은 피부 외용 연고, 크림, 유연화장수, 영양화장수, 팩, 에센스, 헤어토닉, 샴푸, 린스, 헤어 컨디셔너, 헤어 트리트먼트, 젤, 스킨로션, 스킨소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스처 로션, 영양로션, 마사지 크림, 영양크림, 모이스처 크림, 핸드 크림, 파운데이션, 영양에센스, 선스크린, 비누, 클렌징폼, 클렌징로션, 클렌징크림, 바디 로션 및 바디 클렌저로 이루어지는 군으로부터 선택된 어느 하나의 제형인 것을 특징으로 하는 주름개선 또는 항노화용 화장료 조성물.According to claim 1, wherein the cosmetic composition is an external skin ointment, cream, supple cosmetics, nourishing cosmetics, pack, essence, hair tonic, shampoo, conditioner, hair conditioner, hair treatment, gel, skin lotion, skin softener, skin toner , Astringent, Lotion, Milk Lotion, Moisture Lotion, Nutrition Lotion, Massage Cream, Nutrition Cream, Moisture Cream, Hand Cream, Foundation, Nutrition Essence, Sunscreen, Soap, Cleansing Foam, Cleansing Lotion, Cleansing Cream, Body Lotion and Body Cleanser Wrinkle improvement or anti-aging cosmetic composition, characterized in that any one selected from the group consisting of.
  7. 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 개선 및 항노화용 건강기능식품 조성물.Health functional food composition for skin wrinkle improvement and anti-aging containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
  8. 제7항에 있어서, 상기 생강, 창출, 강황 및 육계 추출물의 혼합비는 1:2.5~6.5:2.5~6.5:1 중량비이며, 사상체질 중에서 소음인용인 것을 특징으로 하는 피부 주름 개선 및 항노화용 건강기능식품 조성물.According to claim 7, wherein the mixing ratio of the ginger, the production, turmeric and broiler extract is 1: 2.5 ~ 6.5: 2.5 ~ 6.5: 1 weight ratio, the skin functional improvement food for skin wrinkle improvement and anti-aging, characterized in that the noise is cited in filamentous constitution Composition.
  9. 생강, 창출, 강황 및 육계 혼합 추출물을 유효성분으로 함유하는 피부 주름 예방 및 치료용 약학 조성물.Pharmaceutical composition for the prevention and treatment of skin wrinkles containing ginger, creation, turmeric and broiler mixed extract as an active ingredient.
  10. 제9항에 있어서, 상기 생강, 창출, 강황 및 육계 추출물의 혼합비는 1:2.5~6.5:2.5~6.5:1 중량비이며, 사상체질 중에서 소음인용인 것을 특징으로 하는 약학 조성물.The pharmaceutical composition according to claim 9, wherein the mixing ratio of the ginger, the extract, the turmeric and the broiler extract is 1: 2.5 to 6.5: 2.5 to 6.5: 1 by weight and is used for noise in filamentous constitution.
PCT/KR2016/010842 2016-02-16 2016-09-28 Composition for skin anti-aging and wrinkle reduction, containing medicinal herb mixture extract as active ingredient WO2017142158A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2016-0017794 2016-02-16
KR1020160017794A KR101738339B1 (en) 2016-02-16 2016-02-16 Composition for improving skin aging and wrinkle comprising herbal medicine mixed extract as effective component

Publications (1)

Publication Number Publication Date
WO2017142158A1 true WO2017142158A1 (en) 2017-08-24

Family

ID=59050029

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2016/010842 WO2017142158A1 (en) 2016-02-16 2016-09-28 Composition for skin anti-aging and wrinkle reduction, containing medicinal herb mixture extract as active ingredient

Country Status (2)

Country Link
KR (1) KR101738339B1 (en)
WO (1) WO2017142158A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110326627A (en) * 2018-09-17 2019-10-15 中国医学科学院药用植物研究所 Spray for refreshing air

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102013576B1 (en) 2017-12-12 2019-08-23 한국콜마주식회사 Cosmetic Composition Comprising Mixing Extract of Plant Belonging to the Curcuma Longa and Zingiber Officinale for Improving Skin

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950028734A (en) * 1994-04-02 1995-11-22 조영훈 Color composition for constitution and health promotion
KR20040016471A (en) * 2002-08-17 2004-02-25 주식회사 태평양 A beauty food composition containing oriental medicine extract for improvement of skin condition
KR20100042181A (en) * 2008-10-15 2010-04-23 (주)더페이스샵코리아 Cosmetic compositions containing extract of rheum undulatum and coptidis rhizoma for skin-protection against uv
KR20130023850A (en) * 2011-08-30 2013-03-08 인타글리오주식회사 Cosmetic composition comprising nano capsule containing extract of camellia sinensis, curcuma longa, magnolia obovata and aralia continentalis and manufacturing method thereof
KR20150014022A (en) * 2013-07-26 2015-02-06 주식회사 알파크립텍 Cosmetic composition for wrinkle improvement comprising atractylenolide Ⅲ as effective component

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR950028734A (en) * 1994-04-02 1995-11-22 조영훈 Color composition for constitution and health promotion
KR20040016471A (en) * 2002-08-17 2004-02-25 주식회사 태평양 A beauty food composition containing oriental medicine extract for improvement of skin condition
KR20100042181A (en) * 2008-10-15 2010-04-23 (주)더페이스샵코리아 Cosmetic compositions containing extract of rheum undulatum and coptidis rhizoma for skin-protection against uv
KR20130023850A (en) * 2011-08-30 2013-03-08 인타글리오주식회사 Cosmetic composition comprising nano capsule containing extract of camellia sinensis, curcuma longa, magnolia obovata and aralia continentalis and manufacturing method thereof
KR20150014022A (en) * 2013-07-26 2015-02-06 주식회사 알파크립텍 Cosmetic composition for wrinkle improvement comprising atractylenolide Ⅲ as effective component

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110326627A (en) * 2018-09-17 2019-10-15 中国医学科学院药用植物研究所 Spray for refreshing air

Also Published As

Publication number Publication date
KR101738339B1 (en) 2017-05-22

Similar Documents

Publication Publication Date Title
US6468564B1 (en) Topical compositions containing lotus for skin treatment
US5925348A (en) Methods utilizing compositions containing sacred lotus (methyltransferase) to treat aging skin
US8293291B2 (en) Methods and compositions for reducing the appearance of dynamic facial wrinkles
JP6446120B2 (en) A composition for improving skin containing pomegranate concentrate as an active ingredient
TWI500428B (en) Sugar-free pineapple extract, method for producing the extract, and application of the extract
KR101105542B1 (en) Cosmetic composition for sliming
KR102083294B1 (en) A composition for skin reproduction containing extracts of abeliophyllum distichum and extract thereof having skin reproduction effect
KR102326796B1 (en) Cosmetic materials composition for skin anti-oxidant and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof
CN109152938A (en) For skin makeup or the Herba Saxifragae extract of therapeutical uses
WO2017142158A1 (en) Composition for skin anti-aging and wrinkle reduction, containing medicinal herb mixture extract as active ingredient
KR101547758B1 (en) Composition for preventing hair loss and promoting hair growth
KR102160978B1 (en) Cosmetic materials composition for skin trouble care and skin-soothing, Cosmetic materials using the same and Manufacturing method thereof
CN110101587A (en) A kind of anti-inflammatory anti-acne facial treatment milk
CN111821228A (en) Composition for removing yellow and resisting skin photoaging and application thereof
KR20200140921A (en) Composition for the prevention or treatment of skin aging or dermatitis comprising extracts of Gyeji, gold and silver flowers, scented oil, Schisandra chinensis, wubangja, and Mokdanpi, and method using the same
WO2017094959A1 (en) Composition for improving skin aging and wrinkles, containing scutellaria baicalensis and raphanus sativus l. mixture extract as active ingredient
KR101738340B1 (en) Composition for improving skin aging and wrinkle comprising Coptis teeta and Trichosanthes rosthornii mixed extract as effective component
KR102144566B1 (en) A composition for preventing or terating atopic dermatitis comprising lycopi herba extract as an active ingredient
CN110327268A (en) Composition and its application in the personal care product of preparation anti-aging
Thiab et al. A systematic review of randomized controlled trials assessing phytochemicals and natural ingredients for skin and hair care
KR102650192B1 (en) Cosmetic composition comprising snowberry flesh and preparation method thereof
KR101615900B1 (en) Composition containing Curcuma xanthorrhiza for preventing skin aging
KR102431820B1 (en) Cosmetic composition comprising extract of Citrus grandis Osbeck and Dendropanax morbifera
KR20130136602A (en) Cosmetic composition from field waterdrop extract and its fermentation
CN113576972B (en) Whitening and freckle-removing compound preparation taking fresh fructus phyllanthi pulp as main raw material and preparation method thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 16890749

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 16890749

Country of ref document: EP

Kind code of ref document: A1